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This thesis comprises of f ive chapters. The f i rst chapter 
descr ibes a general l i terature survey of the subject matter. 
Start ing f rom the past history of medic inal chemistry, its 
customary to credit ancient scholars in order to i l luminate an 
otherwise defunct period. For example, the Ebers Papyrus of 
Egypt, Ca. 1500 B.C. mentions the use of squi l l as a cardiac 
tonic. Ipecac, f rom Brazil ian Cephaelis species, was used as an 
antiamebic medication. However, their experiments, observations, 
and interpretat ions must be regarded as purely heurist ic, based 
on superst i t ions and misunderstanding of natural phenomena 
and without much predict ive value in therapy. 
Then the research on drug with a major therapeutic action 
is introduced with history of early agents and the discovery of the 
specif ic st ructural types that exert such activi ty. The application 
of increasingly sophist icated methods of st ructural analysis by 
spec t roscopy , isotopic label ing, separa t ion techniques of 
chromatography opened avenues of study from biochemical 
point of view. 
In the modern period a large variation of drugs are discovered 
based on their structural react ivi ty, b io logical and ant ibacter ial 
propert ies. The role of physico-analyt ical and organic chemistry 
In drug designing is worth to mention which provides the best 
solution of the problem developed in biological environment such 
as unrelated factors as loss of drug by adsorpt ion and incomplete 
absorption. 
The impurit ies associated with drugs as a results from many 
sources are therefore the subject of considerable attention by 
both manufacturer and regulatory agencies. The requirements 
for quality, safety and purity requires carefu l thought over 
analytical chemists. The classification of enormous drugs based 
on their chemotherapeutic action became impor tant . 
A number of important def in i t ions, g iven by several 
international organizat ions have been c i ted to apply whatever 
type of sample is to be analyzed. 
The analyt ical method validation which covers the different 
aspects such as (i) calibration curve, (ii) l imit of quantitation/ 
detect ion, ( i i i ) stabi l i ty of sample and (iv) se lect iv i ty have been 
elaborated. 
The second chapter includes the analysis of penicill ins e.g. 
amp ic i l l i n , amoxyc i l l i n and c loxac i l l i n in pharmaceut ica l 
preparations, using volumetric and spectrophotometr ic methods. 
The determinat ion is based on the hydrolysis of penicil l ins with 
sodium hydroxide under the specif ic condi t ions. The hydrolysis 
product is then t i t rated with potassium iodate in dilute acidic 
medium to form a violet red coloured product at the end point. The 
same coloured product is extracted in carbon tetrachlor ide and 
determined spectrophotometr lcal ly at X 520 nm. The react ion 
' ' -^  nr»ax 
mechanism of degraded product is studied using IR, TLC and UV 
spectrophotometry. The stoichiometr ic ratio between the analyte 
(penic i l l ins) and t i trant (KIO3) is eva luated. 
The proposed method is appl ied successful ly for a number 
of dosage forms. The effect of diverse species in the determination 
of ant ib io t ic has been descr ibed. 
In the th i rd, chapter a spect rophotometr ic method for the 
determinat ion of thyroxine sodium has been developed. The 
determinat ion is based on the format ion of a yellow colour 
product formed by the reaction of thyroxine sodium with ni t rous 
acid (sodium nitrite and hydrochlor ic acid) in ethanol : d imethyl 
sulphoxide (SMS0)(1:1) system at 0-5°C. 
Procedure 
To a preceded mixture (temperature range 0-5°C) of 1 ml 
hydrochloric acid and 1 ml of sodium nitrite is added an 
accurately measured volume of thyroxine sodium (0.1-0.9 ml) 
and diluted upto the mark of a 10 ml volumetric flask with 
ethanol-DMSO (1:1) mixture. The contents of the flasks are allowed 
to stand for 20 minutes in ice-cold bath (0-5°C) in order 
to complete the reaction during which time a stable yellow 
coloured product is formed. The absorbance of coloured product 
is measured against a reagent blank a t> .420nm. A tentative 
reaction mechanism of the yellow coloured product has been proposed. 
The present method has been employed for the determination of 
thyroxine sodium in various pharmaceutical preparations. The precision 
and accuracy of the method is studied. The mean standard deviation 
and mean relative standard deviation are found to be 0.48 ^ig/ml and 
1.14%, respectively. The standard addition method has been carried 
for its determination. The effect of various ingredients used in the 
preparation of tablets and their maximum tolerance (mg) are calculated. 
A statistical treatment of data obtained by the recommended method 
and that of the official method have been reported. Beer's law obeyed 
in the concentration range 10-90 |ig/ml with apparent molar 
absorptivity of 4.0 x 10^ I mol"^ cm^ 
In the fourth chapter, the determination and detection of 
trimethoprim is based on its interaction with persulphate as an oxidant 
in the presence of sodium carbonate. The formation of a yellow colour 
may be due to nitroso compound has made the basis of determination 
of trimethoprim which has X at 355 nm. 
' max 
Procedure 
Preparation of calibration graph 
Aliquots of 0.1-0.6 ml of the standard solution are pipetted 
into a series of 10 ml volumetric flasks. Optimum results are obtained 
after addition of 2.8 ml of potassium persulphate and 3.8 ml of 
sodium carbonate. The solutions are heated on a water bath at a 
temperature 100°C for 30 min. to complete the reaction. After cooling 
to room temperature and dilution to 10 ml with distilled water, the 
absorbance of the yellow coloured solution is measured against 
a reagent blank at A 355 nm. Beer's law is obeyed at the 
^ max 
concentration range 10-60 / /g/ml. 
Application of the proposed method 
The proposed method Is used for the estimation of 
trimethoprim in tablets and oral suspensions. A comparative study 
by a reference method Is also performed. One tablet is accurately 
weighed, crushed to finely divided powder, and dissolved in 
ethanol. The undissolved portion is removed by filtration and the 
filtrate is collected in a 10 ml volumetric flask. A 0.10 ml of oral 
suspension is pipetted out (equivalent to 80 mg of trimethoprim), 
dissolved in 10 ml ethanol, and then followed the above procedure. 
Thin layer chromatography 
Aliquot of 0.01 ml of each standard drug solutions of TMP and 
SMX are applied on the silica gel plate with a microsyringe and 
the plates are developed by the ascending technique. A mixture of 
carbon tetrachloride, acetone (6:4) ratio is used as mobile phase. The 
appearance of spots at different positions are located by iodine 
vapours and the R^  of trimethoprim is compared against the 
R^  (ranges from 0.20 to 0.23) of pure TMP under the same 
conditions. The regions containing the respective TMP are 
scrapped from the plate and eluted with 90% aqueous ethanol. The 
TMP contents are then determined spectrophotometrically by the 
recommended method. Beer's law is obeyed in the concentration 
range 10-60 ^g/ml. The relative standard deviation is found 1.4% v\/ith 
99.22% recovery. 
In the last chapter, a kinetic spectrophotometric determination 
of menadione (2-methyl-1,4 naphthoquinone) in pure form and 
pharmaceutical preparations has been described. The interaction of 
menadione with dodecylamine to produce an orange coloured product 
having X at 470 nm. The kinetic studies show first order reaction 
** mix 
for both menadione and dodecylamine. 
Procedure 
In 10 ml volumetric flasks, the final concentration of the 
standard pure solution of menadione ranging from 5.81 x 10* 
*-4.65 X 10-^  mol/l are placed, and 6 ml of 2.7 mol/l dodecylamine 
is added. The flasks are immersed in a water-bath maintained at 
a temperature 33°C. The flasks are taken out consecutively from 
the water bath at a time-interval of 45 sec, cooled at room 
temperature and then diluted upto the mark with distilled ethanol. 
The contents are then transferred to the spectrophotometric cell 
and the absorbance-time curve at 470 nm is recorded. The 
calibration graph is prepared by a plot of log R (initial rate 
of reaction ) vs. log C (menadione concentration). 
Determination of menadione 
Analysis of injection 
A quantity of 10 mg of menadione injection was transferred 
into 10 ml standard flask and diluted upto the mark with distilled 
ethanol to produce a final concentration of 5.81 x10-^mol/ l . 
Analysis of tablets 
In routine analysis, two tablets were crushed and grinded 
to a fine powder, and accurately weighed which was equivalent 
to lOmg .The powder was dissolved in ethanol and diluted upto 
the mark in a 10 ml standard flask. The residue was filtered through 
a Whatman filter paper No. 1 with the final concentration of 5.81 x 
10-.^  mol/l. The recommended procedure was followed. The range of 
determination is found to be 10-80 )ig/ml. 
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CHAPTER - 1 
General Introduction 
J 
Medicinal Chemistry has taken a place in many branches of 
chemistry and biological sciences. The earlier name of pharmaceutical 
chemistry reflects that in 19th century, pharmacists working in their 
laboratories focussed on the extraction and purification of naturally 
occurring drugs. In 1876 the pharmacologist Buchheim wrote that "the 
mission of pharmacology was to identify the active substance within the 
[natural] drug, to find out the chemical properties responsible for their 
action and to prepare synthetic analogs that were more effective" (1). 
The.pharmacologists later became preoccupied with other objectives, 
such as "to study the change brought about by the drug in the organism 
and then to explore the possible influence of such changes upon 
pathological condition" (1), while the chemist took over the role of 
isolation and chemical identification of biologically active constituents 
from the medicinally important plants. 
Drug design has also been aided by the understanding of 
biochemical metabolism and biosynthesis, and also by the statistical 
analysis of some relationship of physical properties of the chemicals and 
their biological performance. This progress has begun to elevate medicinal 
chemistry to a science in its own right. 
The fashion in which a drug is searched changes, from time to 
time which is dictated by contemporary medical, economical, sociological, 
and sometimes even political considerations. In 1890, antiprotozoal 
chemotherapy set in motion and the early synthetic antimalarials 
intermingled with the development of hypnotics and anti-inflammatory 
drugs. Then followed the feverish discovery of antibacterials and 
antibiotics, while in pharmacodynamics area the potent analgetics, 
antihistaminics, vitamins and new hormones moved to the fore. The post-
world war II period featured three major breakthroughs in drug research 
: (i) the antituberculous agents, (ii) the steroid hormones and 
contraceptives, (iii) the antipsychotic, anxiolytic and antidepressant 
psychopharmacological drugs. 
The application of increasingly sophisticated methods of 
structural analysis like spectroscopy, isotopic labeling, automated 
quantitative analysis, separation by chromatography and other partition 
procedures opened avenues of study of minute amounts of biochemicals. 
Hahnemann,thefounderofhomeopathy, believed that, "Drugs 
solution should be diluted to the point of practically omitting their content 
of active components because high concentrations of drugs produce 
toxic reactions", hence he called it as "Similia Similibus Curantur". 
Thomson stated that "all the diseases are the effect of one general cause 
and may be removed by one general remedy" (2). Paul Ehrlich, a 
German Physician and immunologist turned chemist is the first true 
exponent of durg research as we know it today (3). 
During the period 1940 to 1960, the drug development, 
introduction and pharmaceutical manufacturing entered their "golden 
age". A very large proportion of the important and innovative new drugs 
in medical use were introduced during this period. Public expectations of 
new "miracle drugs" led to increased funding of medicinal research. 
especially by the National Institute of Health in the United States and by 
a number of wealthy private foundations in several countries. 
It is important to recognise that all drugs contain impurities. 
These impurities result from many sources; like from raw materials and 
reagents as reaction by-products, and through degradation during 
manufacture and storage. Since, the impurities can have safety and 
efficiency implications, they are, therefore, the subject of considerable 
attention by both the manufacturers and regulatory agencies. Impurities 
can be classified into three groups, namely organic, inorganic and 
residual solvents. Organic impurities may arise from starting materials, 
intermediates and synthetic by-products, or from reagents and catalysts, 
or as a consequence of degradation. Inorganic impurities may result from 
reagents, ligands or catalysts, as heavy metals or inorganic salts. 
Residual solvents are inevitable in drug substances since without 
solvents, the synthetic chemistry, purification and generation of the 
desired crystal morphology would be impossible. 
Qualification is defined as "the process of acquiring and 
evaluating data which establish the biological safety of the individual 
impurity or a given impurity profile at the levels specified". Thus, the 
pharmaceutical analyst and toxicologist must work hand in hand 
throughout the pre-chemical and clinical development programme 
in order to be able to set meaningful specification requirements. 
The methods used for impurities measurements, 
determinations and qualifications will be addressed in more detail in 
the coming pages. The pharmaceutical analyst must give careful 
thought to the analytical technology. Especially in the development 
phases, it may be necessary to utilize methods with high selectivity, 
including sophisticatedtechniques. The importance of qualifying impurity 
profiles is also relevant to the development scientists to ensure 
consideration is given to the impurities present in batches being used in 
safety studies, although there are opportunities to carry out metabolic 
studies to help in the qualification processes. 
The validation of analytical methods used in bioavailability, 
bioequivalence and pharmacokinetic studies in humans and animals has 
been the subject of discussion in recent years (4-8). It has been agreed 
that the key for evaluation of method reliability and overall 
performance are : (i) analyte stability; (ii) method selectivity ; (iii) limit 
of quantitation; (iv) accuracy and precision; (v) relationship between 
response and concentration (vi) recovery; and (vii) ruggedness. Before 
an analytical method can be used for routine analysis, it must first be 
demonstrated that the method fulfils certain performance criteria. When 
this has been documented, the method is said to be validated. The first 
and one of main difficulties for the practising analytical chemist is to 
decide exactly which parameters should be measured and to set the 
performance criteria which have to be fulfilled before a method can be 
said to be validated. Once the parameters have been fixed, it must be 
shown that they meet the performance criteria. How to do this is the 
second difficulty that is faced by the analyst. However, for a number 
of years analytical chemists In the pharmaceutical and biomedical 
fields have learnt how to demonstrate that their methods have a 
performance that can guarantee reliable results. After the advent of 
good laboratory practice. We know this exercise as validation of 
analytical methods. In the field of drug analysis, it is very clear that the 
above definitions cover the entire field of analytical chemistry from 
bioanalysis to substance and product analysis. This is an important 
observation as the same principles should apply whatever type of 
sample is to be analyzed. There are a number of definitions given 
by several international organizations (Table 1.1). Most of them are 
congruent. 
Table 1.1 
Validation of analytical methods - international definitions 
Organization 
lUPAC 
ILAC 
WELAC 
ICH 
ISO 
Applicability 
Worldwide 
Worldwide 
Europe 
Europe, Japan, USA 
Worldwide 
Remarks 
-
Pharmaceutical 
products 
Lacks selectivity 
and specificity 
ABBREVIATIONS 
lUPAC - International Union of Pure and Applied Chemistry; ILAC - International 
Laboratory Accreditation Conference; WELAC - Westren European Laboratory 
Accreditation Cooperation; ICH- International Conference on Harmonization; ISO 
- International Organization for Standardization. 
Some controversy arises in understanding the differences between 
the selectivity, sensitivity, accuracy, bias, trueness, precision, 
repeatability, reproducibility, reproducibility conditions, intermediate 
precision conditions, and many other aspects of the definitions of the 
validation of the analytical methods. Many papers have been published 
(9-11), including a conference meeting to achieve an important aim in 
bringing scientists together to discuss essential principles for the 
validation of an analytical method and to set minimum standards for 
method performance. 
Prerequisites To IVIethod Validation : 
Developing of analytical method is the first prerequisite for 
the method to be validated. The purpose of method validation is 
to establish that an accurate, precise and rugged method has been 
developed. 
Selectivity/Specificity : 
It Is recommended that the selectivity of the method should be 
established with respect to endogenous substances, metabolites and 
known degradation products. Interferences which are likely to be present 
in small quantities may adversely affect the quantitation of unknown 
samples at concentrations approaching the limit of quantitation (LOQ). 
However, the above terms can be defined from qualitative as 
well as quantitative point of view, when one is involved in the preperatlve 
work. 
specific Test Procedure : 
A procedure to measure quantitatively a chemical-physical 
parameter or functional group of one or more different analytes in the 
sample matrix, e.g. titration of the carboxylic group of an acid, 
measure of the specific absorbance, immunoassay. 
Selective Test Procedure : 
A procedure to detect qualitatively the analyte in the presence of 
components which may be expected to be present in the sample 
matrix, e.g. chromatography, selective electrode. 
A clear distinction should be made between the terms 
specific and selective. A specific reaction or test is one that occurs 
only with the substance of interest. While a selective reaction or test is 
one that can occur with other substances but exhibits a degree of 
preference for the substance of interest. Few reactions are specific but 
many exhibit selectivity. To visualize the difference between 
specificity and selectivity a graphical representation is given in Fig. 
1.1. 
^°°* ^ •specfic 100^4 
Signal from 
analyte only 
Signal from 
analyte only 
Non - specific 
Not to be "scaled" or granded ° Degree of selectivity (%) 10° 
(a) (b) 
Fig. 1.1. Graphical demonstration of selectivity and specificity. The percentage 
of the measured signal attributable to the analyte alone (on the y-axis) 
is given as a function of the degree of selectivity (b). A perfectly 
selective method is said to be specific (a). 
Some analytical definitions from international organization 
for standardization (ISO) are stated as follows :-
Accuracy : 
The closeness of agreement between the result and the accepted 
reference value. Note - the term accuracy, when applied to a set of 
observed values, describes a combination of random components and a 
common systematic error or bias component. 
Bias : 
The difference between the expectation of the test results and an 
accepted reference value. Note - bias is a systematic error as contrasted 
to random error. There may be one or more systematic error components 
contributing to the bias. A larger systematic difference from the accepted 
reference value is reflected by a larger bias value. 
Trueness : 
The closeness of agreement between the average value obtained 
from a large series of test results and an accepted reference value. Note 
- the measure of trueness is usually expressed in terms of bias. 
Precision: 
The closeness of agreement between Independent test results 
obtained under prescribed conditions. Note - (1) Precision depends only 
on the distribution of random errors and does not relate to the true 
value or the specified value. (2) The measure of precision is usually 
expressed in terms of imprecision and computed as a standard 
deviation of the test results. Higher imprecision is reflected by a large 
standard deviation. (3) Independent test results mean results 
obtained in a manner not Influenced by any previous results on the same 
or similar material. 
Repeatability : 
Precision under repeatability conditions. 
Repeatability Conditions : 
Conditions where independent test results are obtained with the 
same method on identical test material in the same laboratory by 
the same operator using the same equipment within short intervals of 
time. 
Reproducibility : 
Precision under reproducibility conditions. 
Reproducibility Conditions : 
Conditions where test results are obtained with the same method 
on identical test material In different laboratories with different operators 
using different equipments. 
Intermediate Precision Conditions : 
The M-Factor for different intermediate precision conditions 
(M=1,2 or 3) are: (a) M=1 where only one of the three factors 
(operator, equipment or time) is different, or where the equipment is 
recalibrated between successive determinations; (b) M=2 where two of 
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the three factors are different; and (c) M=3 where all three factors are 
different between successive determinations. 
The importance of analytical chemistry can be illustrated by 
considering its impact on clinical analysis in pharmaceutical research, 
quality control and in environmental analysis. In the past, medical 
profession used clinical results qualitatively and many of their 
diagnoses were based on symptoms and/or X-ray examinations. Currently, 
over one billion laboratory tests are performed all over the world in 
clinical laboratories per year. The major portion ofthese tests deal with 
blood and urine samples and include the determination of glucose, urea 
nitrogen, protein nitrogen, sodium, potassium, calcium, uric acid and pH. 
In the pharmaceutical industry the quality of the 
manufactured drugs, in tablets, solution and emulsion form, must be 
carefully controlled. Slight changes in composition or in the purity of drug 
itself can affect the therapeutic values. In other pharmaceutical studies, 
it is neccessary to establish the properties and therapeutic value of 
a drug before it is approved and made available to the public. 
Establishment of the permissible level of dosage of a drug requires the 
determination of its composition, its toxicity and its metabolite at various 
stages. 
It is an important task for the practicing analytical chemist 
to choose an aniytical method which provides the best solution to the 
problem. Methods of quantitative testing and quality control of 
pharmaceuticals are controlled by Federal Drug Administration (FDA). 
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Pharmaceutical analysis, today, is on the frontiers of 
analytical chemistry. Analysis in both bulk as well as dosage forms is 
important. The matrix in many cases may be extremely complex and, 
therefore, detection, determination and some form of separation is 
usually required. Usually methods should be comparable to or 
improvement over methods published from standard (B.P.,U.S.P.,I.P.) 
pharmacopoeia laboratories. 
The analysis of a medicinal compound or mixture is generally 
performed for one or more purposes. Either one or more active 
principles, in a known substance, are required to be accurately 
estimatedforthepurposesofstandardization, proof of purity, commercial 
valuation, or in chemico-legal cases, in which case it may perhaps, 
more properly, be called an assay, or, all of the essential ingredients 
of an unknown medicine are required to be at least approximately 
separated and determined where this is possible for the purpose of 
obtaining some idea of the relative merits or demerits of the mixture, 
or perhaps for the purpose of duplication (13). 
All the drugs in their nature are divided into inorganic and 
organic. Both can be prepared from natural sources, or artificially i.e. 
synthetically. The enormous number of drugs used in medicine can be 
classified into two ways : 
1. Pharmacological Classification : 
In this section, drugs are divided on the basis of their action on 
an organism (the heart, brain, lymphatic system, stomach, intestine 
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etc.) Accordingly, drugs are divided into such groups as 
narcotics,soporifics, analgesics diuretics and local anaesthetics. 
2. Chemical Classification : 
Here, the drugs are divided according to their chemical structure 
and properties regardless of their pharmacological action. It is beyond 
the scope of this thesis to discuss all the type of drugs, however, few 
important classes of compounds used as drugs are discussed below. 
Alkaloids : 
Alkaloids are substances mostly of plants and rarely of animal 
origin. In medicine, alkaloids are successfully used as drugs in the 
treatment of cardiovascular, nervous, alimentary trace and many other 
diseases (14). They are organic substances of basic nature because 
their molecules always contain nitrogen. The alkaloids are chiefly 
tertiary amines, and only some of them are secondary amines or 
derivatives of tetrasubstituted ammonium bases. Such class of drugs 
can be grouped into the following heads. 
(I) Pyridine and piperidine derivatives(labeline and Its companions) 
(ii) Tropane derivatives (atropine, hyoscyamines, cocaine etc.) 
(iii) Quinoline derivatives (quinoline, quidine etc.) 
(iv) Isoquinoline derivatives (opium) 
(v) Indole derivatives (physostigmine, reserpine etc.) 
(vi; Imidazol derivatives (Pilocarbine, omeperazole) 
(vii) Purine derivatives (caffeine, theobromine, theophyllin etc.) 
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Antibiotics : 
Antibiotics are very important class of pharmaceuticals 
consisting of antibacterials, antiinfectives, antifungals, antiparasitics 
and anti-microbials. Antibiotics are organic compounds derived from 
or produced by living organisms, which are capable, in small 
concentrations, of inhibiting the life processes of microorganism (15). 
The chemistry of antibiotics is so varied that a chemical 
classification is of little value. However, some antibiotics are the 
products of similar mechanisms in different organisms and that these 
structurally similar products may exert their activities in a similar 
manner. A number of antibiotics have in common a macrolide 
structure, a large lactam ring. Erythromycin, oleandomycin are included 
In this family. Tetracycline family represents a group of compounds very 
closely related chemically. Streptomycins, Kanamycins, neomycins, 
paramomycins and gentamycins are included into a family of compounds 
containingcloselyrelatedaminosugarmoities. The antifungal antibiotics 
nystatins and amphotericins are examples of a group of conjugated 
polyenes. The penicillins and cephalosporins are antibiotics derived 
from amino acids. A large number of polypeptide compounds that exhibit 
antibiotic action include bacitracine, tyrothricins and polymixins. 
Analgesics: 
A drug which brings about insensibility to pain without loss of 
consiousness is known as analgesic. There are numerous drugs which, 
in addition to possessing distinctive pharmacologic activities in other 
grouped as sedatives (e.g. barbutrates) muscle relaxants, tr^nquiiizws 
(e.g. meprobamate), morphine and related compounds (e.g. morphine, 
hydromorphine and codeine phosphate/sulphate etc.) synthetic 
analgesics (e.g. pentazocaine, methotrimeprazine, methadone 
hydrochloride, nefopam etc.), antipyretic analgesics (e.g. salicylic acid 
derivatives, arylacetic acid derivatives, aniline and p-aminophenol 
derivatives, pyrazolone and pyrazolidine dione derivatives). Some of 
them have been quantitatively analysed in pharmaceutical preparations 
and drug formulations (17-20). 
Central Nervous System Depressants : 
The agent that produce depressant effect on the central nervous 
system (21) as their principal pharmacological action, include the 
general anesthetics, hypnotic sedatives, skeletal muscle relaxants, 
tranquilizing agents and anticonvulsants. The general anesthetics (e.g. 
ether) and hypnotic sedatives (e.g. phenobarbital) produce generalized 
or non-selective depression on C.N.S. function. Many sedatives if 
given In large doses produce anaesthetic effect. Certain analgesics also 
produce depression on central nervous system. 
Central Nervous System Stimulants : 
Central nervous system is a complex network of sub-units v>/hich 
act as conducting pathways between peripheral receptors and 
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effectors, enabling one to respond to his environment. Drugs which 
have in common the property of Increasing the activities of various 
portions of the central nervous system are called central nervous system 
stimulants (22). 
Respiratory Stimulants and Analeptics: 
Carbonic acid isa most effective respiratory stimulant. Analeptics, 
agents used to lessen narcosis brought about by excess of depressant 
drugs often stimulate a variety of nerve centres as well as many 
analeptic durgs are also predecessor drugs because their stimulation 
of the vasomoter centre produce an increase in vasoconstriction. 
There are many drugs (e.g. cocaine, atropine, amphetamines, 
ephidrine etc.) of varying pharmacologic classes, which in addition to 
their desired effect, elicit a pronounced stimulatory effect on central 
nervous system. 
Cardiovascular Agents : 
Agents used for their action on the heart or on other parts of 
the vascular system to modify the total output of blood for the 
distribution to certain parts of the circulatory system, are called 
cardiovascularagents. This class include cardiotonic drugs vasodialators, 
hypotensive drugs, antihypercholesterolemic drugs and sclerosing agents 
(23). Certain drugs have a direct action on cardiovascular system, and 
in addition, they affect certain constituents of blood. The later include 
anticoagulant drugs, the hypoglycemic agents, the thyroid hormones and 
the antithyroid drugs. 
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ANALYSIS OF DRUG 
The methods for analyzing medicinal agents are divided into 
physical, chemical, physico-chemical and biological ones. 
Physical methods of analysis involve the studying of the 
physical properties of a substance. They include the determination of 
solubility, transparency and the degree of turbidity, colour, density or 
specific gravity, melting, boiling and freezing points. 
Chemical methods used for the analysis of drugs are 
based on chemical reactions. They include the determination of ash 
content, the hydrogen ion concentration (pH) of medium and characteristic 
numerical indices of oils and fats. Quantitative and qualitative analysis of 
drugs are generally carried out with respect to functional groups. 
Physico-chemical methods are used to study the physical 
phenomenon that occur as a result of chemical reaction. Among the 
physico-chemical methods of analysis are, photometry including 
photo-colorimetry and spectrophotometry, electrochemical and 
chromato-graphic methods. Recently, various kinds of chromatography 
(column, paper, thin layer, gas, gas-liquid) and photometric methods 
based on the absorption of light by the analyte have found their use in 
pharma-ceutical analysis. NMR, and mass spectrometry with gas 
chromato-graphy are the most important analytical methods used for the 
analysis of drug. 
Biological methods of analysis characterize the pharma-
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ceutical effect of the drug. Biological tests are conducted on animals 
and less frequently on separate isolated organs or part of organs of 
animals. The effect of drug is expressed in A.U. (Activity Units) and 
is determined by the comparison with the acitvity of a reference 
substance. The biological methods are very sensitive. Alkaloids, 
vitamins and antibiotics, still reveal activity when diluted millions of 
times. 
Photocolorimetric methods of analysis are based on 
measuring the absorption of non-monochromatic light by coloured 
compounds, in the visible part of the spectrum. If the analytes are 
coiourless, they are converted into coloured compounds by reaction with 
suitable reagent. In the visual method, called colorimetry, the intensity 
of the colour of analyte solution is compared to that of standard 
solutions if the concentration of substance is known. 
In recent years, pharmaceutical analysis has been 
characterized by the use of methods such as flame photometry and 
differential spectrophotometry in the qualitative analysis of drugs. These 
methods enable one to determine the large amount of individual 
components of a mixture because the absorbance of the analyte 
solution is measured not relative to the pure solvent (or a solution 
of reagent) but relative to a reference solution containing a known 
amount of the analyte. 
In capillary electrochromatography (CEC), a liquid mobile 
phase is driven through a stationary phase in a packed capillary 
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column by the electro-osmotic flow (EOF) generated by a large difference 
in potential across the column (24-25). There is no pressure drop, and 
it follows that the flow profile is rectangular and that small diameter 
particles may also be employed. Higher column efficiencies can, 
therefore, be obtained than in pressure driven HPLC. While much 
interest has been shown in the theory and mechanism of CEC, Its 
development and eventual widespread use in the pharmaceutical 
industry will only come about if CEC is shown to have advantages 
over more conventional HPLC in routine use. 
CEC can be applied with considerable advantages in the 
analysis of pharmaceutical compounds. Separations are efficient, 
repeatable and reproducible. As long as the system is pressurized 
and the column temperature controlled, quantitative analysis can be 
carried out with electrokinetic injection. CEC has been applied 
to the separation of several pharmaceutical compounds; a mixture of 
diastereoisomers, not previously separated on a chiral HPLC 
column, was separated by CEC(26). 
Derivative spectrophotometry presents greater selectivity 
than does normal spectrophotometry and so offers a convenient 
solution to the problem of resolving spectral overlap in the analysis of 
multlcomponent system (27-28). Peak-to-peak and base-line 
measurements (generally referred to as graphical measurements) and 
zero-crossing measurements are the most common techniques used to 
prepare analytical working curves. The zero-crossing method involves 
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the measurement of the absolute value of the total derivatives 
spectrum at an abscissa value (v\/avelength) corresponding to the zero-
corssing point of the derivatives spectrum of the interfering component. 
At this wavelength, the amplitude of the derivative signal of one of the 
two components passes through zero; measurement of the value of the 
derivative spectrum of a mixture, made at the zero-crossing point of the 
derivative spectrum of one of the components is therefore a function 
only of the concentration of other component (29). 
O'Haver (30) discussed the potential of derivative 
spectrophotometry in clinical chemistry. Fell (31) has demonstrated the 
possibilities offered by this technique for the analysis of pharmaceutical 
formulations. The simplicity, precision and selectivity of derivative 
spectrophotometry make it particulary suitable for the simultaneous 
analysis of binary mixtures of compounds having overlapping spectra. 
Difference spectrophotometry has proved particularly 
useful in the determination of medicinal substances by eliminating 
specific interference from degradation products, co-formulated drugs 
and also the non-specific Irrelevant absorption from the formulation 
matrix. Its advantages for selective analysis have been described by 
several workers (32-33). The technique involves the reproducible 
alterations of the spectral properties of the absorbance difference 
between two solutions provided that the absorbance of the other 
absorbing substances is not affected by the reagents used to alter 
the spectral properties. Simple aqueous acids, alkalis and buffers are 
20 
most frequently used for inducing, spectral alteration since many drugs 
are weak acids or bases whose state of ionization and absorptivity 
depends on the pH of the solution (34). 
Flow injection analysis (FIA) is characterized by its 
simplicity, speed and the use of inexpensive equipment. Its results are 
accurate and precise, and there are clear advantages in terms of the 
short time required for each assay. The usefulness of the (Fl) method for 
routine analysis has been shown in a large number of determinations 
developed for clinical, pharmaceutical, food and environmental 
analyses. 
High performance thin-layer chromatography (HPTLC) 
is particularly attractive as an analytical tool as it is the fastest 
chromato-graphic technique and flexible enough to analyse different 
kinds of samples. It is an off-line technique where every stage of the 
analysis can be visualized. HPTLC depends on the object, scanning is 
performed in reflectance or in transmittance made by absorbance or by 
fluorescence. It can be used in pharmaceuticals (e.g. uniformity of 
content impurity profile, limit tests, bioavailability and bioequivalence), 
medical, biological/clinical areas. 
Electrochemical methods are characterized by high 
sensitivity, selectivity and accuracy. Analytical sensitivity attainable 
even exceeds pg/ml level and analysis in the nanogram or 
subnanogram range is possible. Electrochemical methods have been 
extensively developed and each basic electrical parameter namely 
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current (i), resistance (r) and voltage (v) has been utilized alone or in 
combination for analytical purposes. Electrochemical methods have 
entered a new phase since development of electrochemical detectors 
for HPLC. These are amperometric or coulometric detectors which 
measure the current associated with the oxidation or reduction of 
solute. Pharmaceutical drugs containing groups such as phenolic, 
amino, heterocyclic nitrogen, keto and aldehyde undergo oxidation at 
characteristic potential. Since all compounds do not undergo oxidation 
at a particular potential applied, this increases the selectivity of 
the technique. Electrochemical detection is often used where 
ultraviolet detectors do not have sufficient sensitivity. 
As many drugs (nifedipine, methyldopa) tend to degrade 
rapidly in dilute aqueous solutions, simple and rapid analytical methods 
should be used in the analysis of dissolution fluids for the dissolved 
drugs. The chosen method must possess sufficient sensitivity as with 
very potent or controlled - release drugs the total amount dissolved 
may be very small (e.g. 1 mg) and the amount dissolved early in the 
test could be even smaller. Furthermore, the analytical method should 
be specific enough to differentiate the drug from the soluble excipients, 
impurities and degradation products. 
Conventional UV spectrophotometric methods are simple, 
quick, economical and usually do not require an elaborate preparation 
step prior to assay. However, a UV method is not adequate when 
two or more drugs with similar UV spectra are present in the sample, or 
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excipients or decomposition products exhibits UV interferences, as the 
case with the dissolution testing of phenytoin capsules (35). 
The determination of drugs and their metabolites is 
becoming increasingly important in the pharmaceutical and biomedical 
fields. Successful analyses demands sensitivity, at the parts-per-
billion level or lower, high sensitivity and rapidity from the methods used 
to implement them. They require not only quality analytical results 
but also strict quality assurance in both procedures and data. Modern 
approaches to biopharmaceutical analysis rely mainly on chromatographic 
and immunochemical methods, which are often time consuming. 
Immediate availability of a result is mandatory in many cases. In this 
respect, the worth of one analysis is inversely proportional to the 
time it takes : 
analysis 
Value = ^ 
time 
Laboratory automation through modern instrumental analysis and 
computers and low-cost microprocessors is essential for shortening 
analysis time in order to achieve high quality routine analyses. Kinetic 
automatic methods are good choices for drug analysis as they permit the 
sensitive and selective determination of many drugs within a few 
seconds with no sample pretreatment in many cases. Moreover, the 
instrumen-tation required is generally very simple. 
The principle and applications of the kinetic methods have 
been reviewed (36) and appeared in monographs (37-38). Essentially, 
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kinetic methods rely on measurements of concentration changes 
(detected via signal changes) in a reactant (which may be the analyte 
itself) with time after the sample and reagents have been mixed. 
The use of kinetic methods in micellar media (39) is 
another recent approach to kinetic-based determinations that have 
proved useful in drug analysis. Micelles increase the reaction rate 
(through micellar catalysis) and may additionally increase the 
sensitivity and selectivity for the analyte. On the other hand, new 
kinetic chemometric(kinetometric) approaches such as the Kalman 
filter has been developed and applied to the simultaneous 
determination of various compounds of pharmaceutical interest. 
The analysis of drug entails, essentially, the following : 
(1) the quantitative, qualitative and relative bioactivity assay of pure 
and impure drugs in different matrices; (2) elucidation of the 
mechanism of action of drugs at the molecular level; (3) clinical evaluation, 
including assessment of site of action (in vivo) and side-effects, and 
methods of assaying development of resistance of cells to drug action. 
Methods of quantitative and qualitative analysis of drugs are 
important in all three aspects. Quantitative drug measurements 
require to be of high reproducibility, precision and accuracy and should 
be efficient. In clinical laboratories there are usually a very large 
number of samples derived from different sources to be dealt with 
(40) Metabolic studies of drugs require detection at very low levels, 
often in the ^g-ng range, in body fluids and tissues. Drug abuse also 
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leads to a need for rapid qualitative and quantitive analysis of drugs, 
is also important in the pharmaceutical industry, but because dosage 
forms are of high purity and precisely known composition the limits 
of detection are not so demanding as in clinical medicine, and 
reasonably large quantities of sample are usually available. 
The methods currently available may be broadly divided into two 
categories: (1) classical microbiological methods (41) and modifications 
thereof; (2) physicochemical techniques (42). 
Microbiological assays may be considered as variants of chemical 
assays in which a living organism or tissue is the reagent responding 
to the substance under investigation. The classical techniques can be 
classified into (a) diffusion methods and (b) dilution techniques. 
The diffusion methods are based on the uniform spread of an 
inhibitor into a solid medium from its point of application. As the 
inhibitor agent spreads, its concentration decreases. Organisms will 
grow only where the concentration of inhibitor is too low to stop 
growth. The diffusion methods are not well understood theoretically. 
The inhibition zone diameter is usually (but not always) proportional 
to the logarithm of the inhibitor concentration, and is affected by various 
experimental factors. Synergistic or antagonistic effects of drug molecules 
on micro-organisms are also difficult, if not impossible, to assess by 
plate agar diffusion methods. 
Respirometric methods depend on the ability of a drug to inhibit 
formation of carbon dioxide by either direct or indirect action. 
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Radioactively labelled carbon dioxide, and Warburg or indicator methods 
can be used, but the indicators should not interfere by complexing 
with the drug. 
Turbidimetric methods measure the inhibition of growth photo-
metrically. The growth is assumed to be inversely proportional to the 
drug concentration. Errors can be caused by variation in inocula, inoculum 
volume errors and light-absorption by the drug. 
In dilution methods, several dilutions of the drug are incubated 
with an Inoculum of test organisms, and the lowest concentration of drug 
producing complete inhibition of growth is taken as the inhibitory 
concentration. 
Numerous variations of these techniques continue to be 
reported, and routinely practised in clinical and pharmaceutical 
laboratories. One of the primary reason for this is that the structure 
of the drug need not be known. The methods are also usually cheap 
and simple and do not need elaborate apparatus, but are slow, have 
rather poor reproducibility and precise, are open to subjective error, 
and cannot be used qualitatively. 
The availability of sub-standard medicines to the general public 
poses many problems, both clinically and economically. It is widely 
believed that such sub-standard preparations are readily available 
in many developing countries(43-44). This may be due to poor 
manufacturing procedures, poor storage conditions or deliberate 
counterfeiting of branded or generic products. However, most literature 
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reports on this problem do not contain quantitative information. 
As part of an on-going study looking at the quality of selected 
pharmaceuticals in developing countries it is necessary to assay 
samples of the drugs in formulations. In examining the quality of the 
active ingredient present, it is of advantage to be able to detect 
starting materials and major decomposition products if these are 
present. This may allow the cause of any lack of quality determined. 
The method employed should allow rapid determination of the drug from 
the dosage forms with little sample pre-treatment. In addition, the 
method should be validated following current guidelines (45-46) and 
in view of this a method is required which is as simple as possible 
so that the validation requirement could be adhered to. 
ANTIBIOTICS 
Antibiotics defined as many micro-organisms produces within 
themselves chemical substances which, when excreted, interfere with 
the growth or metabolism of other micro-organisms, such compound are 
known as antibiotics. Therefore, antibiotics are thus chemotherapeutic 
agents. In 1929, Fleming discovered a mould of the penicillium 
species, which inhibited the growth of certain bacteria. The antibiotics 
cover a wide range of compounds of different chemical structures. 
Penicillins is a name given to the mixture of natural compound having 
the molecular formulla CgH^^NjO^SR, and differring only in the nature 
of R. There are atleast six natural penicillins (Table 1.2). 
Table 1.2 
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Chemical name 
Pent-2-enylpenicillin 
Benzylpenicillin 
p-Hydroxybenzyl-
penjcjiljn 
n-Heptylpenicillin 
n-Amylpenicillin 
Phenoxymethylpenicillin 
Other name 
Penicillin-I or F 
Penicillin-ll or G 
Penicillin-Ill or X 
Penicillin-IV or K 
Dihydro-F-penicillin 
Penicillin V 
R 
-CH2CH=CHCH2CH3 
-CHjCgH^ 
-CHfi^HpH{^^) 
-(CH,),CH3 
-(CH,),CH3 
- C H p C . H , 
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The first successful synthesis of penicillins was carried out by 
Sheehan et al. (1957, 1959), after 16 years in the preparation of totally 
synthetic penicillins. The general reaction sequence is outlined in Fig. 1.2 
^NCHCHO HSCM*2 
C02CM»3 NH2CHCO2H 
;NCH 
COjCMes " " ^C02H 
" \ 
,NCH — r ' ^ N ^ ^ " ' 
R / I H N _ _ r C H 3 
P dry jHCI 
,NCH 
R^ ' .... . 
CO2H ^C02R' 
~^-^i':\. 
ISOC12 
R. 
\ N - r - T - S ^ C H 3 
R/JXJ^CH, 
H2-P<1 I or OH 
A—M— , 
O^ CO2R' 
'1 
0 ' ^ ' ^ ~ ^ C 0 2 H 
/** ~ ^ J L /'*~'^6"5CH2S02NH-
R ' C C H 3 , C 6 H S C H 2 
Fig. 1.2. Total synthesis of penicillin analogs 
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Ampicillin, (a-aminobenzylpenicillin) and amoxycillin (a-amino-p-
hydroxybenzylpenicillin) are two semisynthetic p-lactam antibiotics 
widely used for the treatment of commonly-occurring bacterial infections. 
Several analytical procedures have been described for the 
analysis of these aminobenzylpenicillins including fluorimetric (47), 
spsctrophotomethc (48-49), e\ectroana\yt\ca] (50), chromatographic (51-
52) and microbiological (53) methods. The spectrophotometric methods 
for ampicillin and amoxycillin determination are mainly based on the use 
of equilibrium methods, which usually involve a previous step where an 
acid(48-49) or base (54) is used to hydrolyse the p-lactam ring. The 
treatments take between 20 min and 2h, so the equilibrium 
determinations involved are very slow and hinder applications to routine 
analysis. Flow injection analysis (FIA) has also been used for the 
determination of amoxycillin and ampicillin (55). 
Ampicillin and cloxacillin are having a similarity in their structure 
(due to the presence of p-lactam and thiozolidine rings), a method 
for their analysis in combined preparations must be designed to 
achieve a high degree of selectivity (56) but only the liquid 
chromatographic methods are selective. 
Penicillins in combinations provides a broader spectrum of 
antibacterial activity and may be advantageously prescribed in cases 
of p-lactamase-producing strains. Synergistic activity of some penicillin 
combinations are reported for gram-negative bacteria (57-58). Synergy 
between amoxycillin (Fig. 1.3(1)) and dicloxaciJIin (Fig. 1.3(1))) has been 
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demonstrated against clinical isolates of sonne p-iactamase-producing 
and non-producing strains (59). 
n 
H H 
NH2 A-^' 
0^ 
CH3 
CH3 
N:02H 
Fig. 1.3(1 & II) 
Pharmaceutical preparations containing both the mentioned |3-lactam 
antibiotics are now normally found on the drug market. 
There have been various different analytical procedures 
proposed for the determination of amoxycillin, including 
spectrophotometric measurement of the copper chelate (60) or the 
penicillenic acid formed by reaction with mineral acids and copper (II) 
(61). The British Pharmacopoeia 1988(62), recommends a titrimetric 
procedure for amoxycillin in bulk form using standard mercury (II) 
nitrate and potentiometric detection of the equivalent complex, and 
a colorimetric one using immidazole mercury reagent at 325 nm in 
the case of capsules containing the drug. 
31 
Two chromatographic methods are described for the determination 
of ampicillin in the presence of another penicillin (63-64). The first 
method involved the quantitation of ampicillin embonate and 
amoxycillin embonate (63). The method utilizes a reverse phase 
separation column at pH 7 with detection at 240 nm and amoxycillin 
is used asthe internal standard for ampicillin and phenoxymethylpenicillin 
is used as the internal standard for amoxycillin. Amoxycillin and 
embonic acid are determined simultaneously; however, ampicillin and 
embonic acid require separate analyses. Calibration graphs are linear 
over the range 1.5-21 |ig/ml embonic acid, 10-110 ^g/ml amoxycillin, 
and 50-500 )ig/ml ampicillin. Another method involves the reverse 
phase-18 determination of ampicillin and cloxacillin in capsules (64). 
Sample preparation consisted of a simple dilution with methanolic 
sulphamethoxazole solution followed by direct injection and subsequent 
monitoring at 254 nm. Calibration curves are linear between 0.05 and 
0.6mg/ml with quantitative recoveries and precision of less than 1.1% 
RSD. Other methods for chromatographically determining a single 
penicillin include the determination and monitoring of aziocillin during 
bulk drug analysis (65), the determination of benzylpenicillin in 
pharmaceuticals by capillary zone electrophoresis (66) and a 
collaborative study for determining penicillin V in tablets has been 
carried out (67). 
Several papers have described the use of enzyme selective 
electrodes for determining penicillins (68-69). The effect of pH and buffer 
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concentration on the response of an enzyme membrane coated wire 
electrode Is also described (68). The enzymatic sensor is constructed by 
coating a silver wire with a membrane consisting of 31% carboxy 
substituted PVC, 36% 2-nitrooctyl ether, 5.5% tridodecylamine, 0.5% 
sodium tetraphenylborate and membrane modifications with 
penicillinase. Spectrophotometric methods continue to enjoy popularity 
for the determination of a variety of penicillins. The first-derivative 
mode of operation is found to be simple, accurate, and precise for the 
determination of amoxycillin and clavulanic acid in pharmaceutical 
preparations (70). Second-derivative spectroscopy has been applied to 
quantitation of ampiclllin and dicloxacillin (71), and ampicillin and 
cloxacillin (72). Both methods by Morelli are suitable for the analysis 
of these p-lactams in pharmaceutical preparations. A fourth - derivative 
spectroscopic approach has been described for the determination of 4-
hydroxyphenoxymethylpenicillin in phenoxymethycillin samples (73). A 
second-derivative spectroscopic method described the determination 
of ampicillin and cloxacillin (74). The method consists of dissolution of 
the formulation in water followed by scanning the spectra between 
260 and 330 nm. Derivative measurements are obtained at 269 nm and 
284 nm for ampicillin and cloxacillin, respectively. Beer's law is obeyed 
upto 14mgof each penicillin, and the method has been successfully 
applied to commercial preparations containing both antibiotics. The 
hydrolysis of ampicillin and cloxacillin followed by direct 
spectrophotometric determination at 273 nm has been described (75). 
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The method is found to be specific to ampicillin in the presence of 
cloxacillin and linear from 5 to 35 fag/ml. 
Amoxycillin methods which have been described include the 
second-derivative spectroscopic procedure forthe suspensions (76) and 
liquid chromatographic methods (77). A stability indicating method for 
azioxacillin is described in the literature (78). The method is based upon 
reversed-phase chromatography to separate degradants from the 
active principle at storage conditions of 50°C. Another differential 
colorimetric method has been described for benzyipenicillin (79). The 
method involves hydrolysis of the p-lactam with subsequent reaction 
with ferricyanide. The amount of benzyipenicillin is determined via the 
difference from the hydrolyzed vs. unhydrolyzed sample. The amount 
is also applicable to ampicillin and benzathine penicillin V. Other 
methods described for penicillins include reaction with Ellman's 
reagent (80) and flow injection analysis (81). 
A variety of techniques have been evaluated for the 
quantification of amoxycillin alone or in combination with other 
penicillins (82-84). Micellar electrokinetic capillary chromatograph has 
been found to be a useful approach for identifying degradation products 
in aged amoxycillin (82). In addition, the reaction of amoxycillin with 
acetylacetone-formaldehyde has served as the basis for a simple 
spectroscopic method (83). Beer's law is obeyed from 10 to 100 lag/ 
ml, and no interference is observed in mixtures containing cloxacillin 
and excipients. The simultaneous fluorometric determination if 
34 
amoxycillin and clavulanic acid is possible using a stopped-flow 
kinetics approach (84). The method, which has a linearity of 0.OB-
IS.0 and 0.10-17.6 |ig/ml, respectively, involves the reaction of the 
analytes with acidic Ce (IV) and detection at 365 nm. Another 
spectroscopic method for the ampicillin is carried out using nitrobenzene 
as the colorimetric reagent (85). This new approach offers simplicity, 
rapidity and stability when compared to the British pharmacopoeia 
method. Othertechniques used to assay ampicillin include polarography 
(86), titrimetry (87) and liquid chromatography (88). 
THYROXINE SODIUM 
Thyroxine (89) (Fig. 1.4) is an active substance which is isolated from 
thyroid gland (usually the sheep). It is the tetra-iodo-derivatives of 
amino acid. 
^^  ^ NHi 
)_p^O^H-CH.-
^ ' e 
0 0 NQ 
Fig. 1.4 Thyroxin sodium 
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Thyroxine sodium is a crude salt. It has the several thousand 
times the activity of a fresh gland. Defatted thyroid substance has 
been used for many years as a replacement therapy in thyroid gland 
deficiencies (90-91). The efficacy of the thyroid gland is known to 
depend on its thyroglobulin content v\/hich is an iodine containing 
globulin. Kendall In 1916 obtained thyroxine as a crystalline derivative 
and found that it showed as much the same action as the whole 
thyroid substance. Recent studies show that even more potent iodine 
containing hormone exists, which is known as triiodothyronine. 
Thyroxine is supposed to be the storage form of the hormone. While 
the triiodothyronine is the circulatory form. In the blood thyroxine is 
more firmly bound to the globulin fraction than in triiodothyronine, 
which can then enter the tissue cells. 
Levothyroxine Sodium U.S.P. : 
Sodium L-3-[4-(4-hydroxy-3,5diiodophenoxy)-3,5 diiodophenyl] 
alanine, orsodium L-3, ^,5-^,-tetraiodothyronine(Fig. 1.5). This compound 
is the sodium salt of levoisomer of thyroxine, which is an active 
physiological principle obtained from the thyroid gland of domesticated 
animals used for food by man. It is also prepared synthetically. The salt 
is light yellow, tasteless, odourless powder. It is hygroscopic but stable 
in dry air at room temperature. It is soluble in alkali hydroxides, 1:275 
in alcohol and 1:500 in water to give a pH of ~ 8.9. 
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NH2 
CH2-CHC00-Na 
Fig. 1.5 Levothyroxine sodium 
Levotliyroxine sodium is used in replacement therapy of diseased 
tiiyroid function (liypothyroidism). In general, 100 ^g of levothyroxine 
sodium is clinically equivalent to thyroxine 30-60 mg of thyroid U.S.P. 
Liothyronine Sodium U.S.P. Cytomel : 
Sodium L-3 [4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl] 
alanine Is the sodium salt of L-3,3,5, triiodothyronine (Fig. 1.6). It occur 
as a light tan, odourless, crystalline powder slightly soluble in water or 
alcohol and has a specific rotation of+18° to+22° in acid (HCI) alcohol. 
HO '—0-c H2CHfJH2-C0d.Na 
Fig. 1.6 Liothyronine sodium 
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Liothyronine occurs in vivo together with levothyroxine. It has the 
same qualitative activities as thyroxine but is more active. It is absorbed 
readily from the gastrointestinal tract, is cleared rapidly from the blood 
stream and is bound more closely to the plasma proteins than the 
thyroxine, probably due to the less acidic phenolic hyroxyl group. Its use 
is same as that of levothyroxine, including treatment of metabolic 
insufficiently, male infertility and certain gynecological disorder. 
The determination of iodinated thyronines is of great importance. 
As the concentrations of iodinated thyronines in plasma are very low, 
only trace method can be applied for the determination. Radioimmuno-
assay (92-93), fluorescence immunoassay (94), enzyme immunoassay 
(95) and competitive protein binding assay (96) are most frequently 
usedforthedetermination of thyroxine sodium. A selective determination 
of enantiometric thyronines is not possible with these techniques. The 
reaction of L-thyroxine antibodies with D-thyroxine for a 
radioimmuno-assay is found to be 100% (97). A spectrophotometric 
method of thyroxine sodium determination has been developed (98). 
Recently the determination of DL-triiodothyronine and DL-thyroxine by 
derivatization liquid chromatography has been described (99). TheDL-
thyronines are derivatized with tertiarybutyloxy-L-leucine-N-
hydroxysuccinimide ester and the resulting diasteromeric peptides are 
separated by ion pair chromatography on reversed phase columns. This 
method is successfully applied to control the purity of pharmaceuticals 
and its applications in human plasma seems to be promising. 
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Chromatographic separations of thyroid hormones can be carried out 
using gel chromatography (100-101), ion-exchange chromatography 
(102-103), gas chromatography (102) and high performance liquid 
chromatography HPLC (103). 
The effect oftemperature on free thyroxine measurements and its 
analytical, and clinical consequences are reported (104). Thyroxine and 
3,5,3,-triiodothyroxine have been determined by sub and super 
equivalence isotope dilution analysis (105) at trace level (160 and 20 
i^g/ml) and radioimmunoassay (106) for measurement of free thyroxine 
in serum. New homogeneous enzyme immunoassay for the 
determination of thyroxine and thyroxine uptake have been developed 
recently (107). 
For the analysis of thyroid hormones at low biological levels by 
electron-capture gas chromatography (GC-ECD) (108-109), a convenient 
internal standard is required. The compound should be a good 
electrophore (absorbent of thermal electrons), with as many halogen 
atoms as possible and with a high molecular weight in the range 
of those of very heavy thyroidal substances (110). Capillary gas 
chromatography with fused silica columns and electron capture 
detection (GC-ECD) can be used to analyze the derivatized 
iodothyronlne standards at the pg level under both isothermal and 
temperature-programming conditions (108-109). It Is found that this 
analysis is especially facilitated by the use of short columns and high 
column flow-rates. Further Improvements of the GC-ECD system for 
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the same analysis, mainly involving the injection step, to obtain a good 
precision has been also reported (111). The continuing interest in GC 
is undoubtedly connected with improvement in the associated 
technology which have resulted in the availability of instruments 
suitable for work with capillary columns and selective detectors, i.e., 
high resolution combined with high sensitivity (112). Filter paper and 
thin chromatography (113), ion exchange column chromatography 
(114), gas-liquid chromatography (115) and sephadex gel filtration 
columns (116) have been reported for the separation of mixtures of 
thyroidal iodoamino acids. 
TRIMETHOPRIM 
Trimethoprim (5-[(3,4,5-trimethoxyphenyl) methyl] pyrimidine-2,4-
dlamine) in combination with sulphamethoxazole [4-amino-N-(5-
methyl-3-isoxazoly) benzene-sulphanamide] is an effective antimicrobial 
agent used, for example, in the treatment of urinary tract infections. 
Various analytical techniques are available for the simultaneous 
determination of the compound in pharmaceutical preparations and 
biological fluids. The most widely used method is high performance 
liquid chromatography with reversed-phase (117-118) or normal phase 
(119). The disadvantage of gas chromatography is the need for 
derivatization of sulphamethoxazole before the analysis (120). Nuclear 
magnetic resonance spectroscopy provides an attractive tool for the 
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determination of mixtures of trimethoprim and sulphamethoxazole 
because of the simple sample preparation (121). The methods of 
stepwise potentiometric titration (122) and spectrometric measurement 
in the ultra-violet (123) or visible region after formation of coloured 
products (124) lack selectivity and sensitivity, but are, nevertheless, 
suitable for the quantitation of trimethoprim and sulphamethoxazole 
combination in pharmaceutical dosage forms. Thin layer 
chromatographic (TLC) separation of trimethoprim and 
sulphamethoxazole with subsequent densltometric measurement has 
been described for conventional TLC plates (125). High performance 
thin-layer chromatography (HPTLC) offers some advantages over 
conventional TLC, e.g., better separation properties, increase in the 
number of samples on one plate, and reduction of analysis time and 
solvent consumption. Therefore, Seija(126) has reported the successful 
use of HPTLC for the determination of trimethoprim in the presence of 
sulphamethoxazole where he reported a specific, stability-indicating 
HPTLC for the routine analysis in pharmaceutical formulations. 
Non-aqueous titrimetry (127), HPLC or ultraviolet spectrophoto-
metry (128) have been suggested for the determination of trimethoprim 
alone or mixed with sulphamethoxazole The titrimetric method suffers 
from lack of selectivity, and other basic substances may cause 
interference. The other methods require expensive instrumentation. 
Yao ef a/ (129) found that sulpha-drugs may be determined 
potentiometrically in pharmaceutical preparations containing 
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trimethoprim, by use of an electrode sensitive to the sulpha-drugs, 
therefore, a trimethoprim-selective electrode is reported and proposed 
for use in pharmaceutical analysis. 
Determination of trimethoprim has been extended in lung and 
edible tissue from pigs by multi-dimentional liquid chromatography 
(130). The detection limits in the tissue are 10-50 ng/g. Simultaneous 
determination of sulfadiazine and trimethoprim in plasma and tissue 
of cultured fish for residual and pharmacokinetic studies has also been 
described (131). The sample pretreatment procedures are simple, 
selective and robust having a limit of quantification of 250 ng/ml for 
trimethoprim and 50 ng/ml for sulfadiazine in blood plasma. 
MENADIONE 
Menadione (vitamin Kg) and analogues (naphthoquinones) are of 
considerable importance because of their role in blood coagulation 
processes. Thus, the general term vitamin K3 is used to indicate 
2-methyl-1,4-naphthoquinone and its derivatives. Vitamin K3 plays an 
important role in blood coagulation and bone mineralization (132). The 
two naturally occurring and biologically most important forms are 
phylloquinone (vitamin KJ from plant origin and the menaquinones 
(vitamin K^ series) synthesized by bacteria. The significance of vitamin 
K3 has often been studied with animals, especially poultry, where 
deficiencies are likely to occur (133). For this reason and because the 
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biologically active menaquinone-4 can be formed in vivo from 
menadione (134), the later compound is added to animal feed. To 
improve its stability and absorption efficiency the water-soluble 
derivative menadione sodium bisulphite is often used. Numerous methods 
for the determination of menadione sodium bisulphite in feed have 
been described e.g., gas-liquid chromatographic (GLC) (135), 
colorimetric(136) and HPLC methods (137), however, most of them 
have one or more drawbacks. GLC methods are not sufficiently sensitive 
to determine levels below 4 ^g/g. The official colorimetric method of the 
European Community (EC) for the determination of menadione sodium 
bisulphite in feed (138) includes a time-consuming colour reaction. 
Furthermore, at low levels (1-3 ng/g) the colorimetric measurement is 
often subject to interference by sample components. The sensitivity of 
the HPLC method described by Ranfft and Ruckemann (139) only 
permits determinations in premixes and supplements. The detection 
limit of the HPLC method with post column reaction fluorimetry for 
the determination of phylloquinone and menaquinone-4 in biological 
materials is described(139). These non-fluorescent naphthoquinones 
are reduced to their fluorescent dihydroxynaphthalenes in a post-
column reaction coil. Menadione sodium bisulphite (Vitamin K3) in feed 
and premixes has been determined by HPLC with post-column 
derlvatization(140). Spectrophotometricmethod has been recommended 
for the determination of menadione and analogues (naphthoquinones), 
using titanium (III) (141). Titanium (III) is employed to reduce 
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naphthoquinone to its corresponding napthohydroquinone which 
subsequently forms a high coloured complex with Ti(l\/). The method 
yields highly linear calibration data in the region of 10^ M. Two more 
spectrophotometric methods for the determination of menadione and its 
analogues are described (142). These methods are based on their 
reaction with thiosemicarbazide and ethylacetoacetate forming stable 
coloured species which are measured at 520 nm and 550 nm, 
respectively. They are applied in formulations containing vitamin K 
analogues either alone or in combination with other vitamins. 
A large number of methods have been described for the 
detection and determination of menadione. Menadione has been 
determined by phloroglucinol in alkaline medium (143). The formation 
of a blue colour with 3-ethylrhodamine is used for menadione 
determination(144). Dimethylamine has been used for menadione 
estimation (145). Fluorimetric method has been utilized for the 
determination of menadione(146). Hexane-dichloromethane has been 
used as a normal-phase in HPLC method for the determination of 
menadione in animal feeds and pet food (147). HPLC methods are 
adopted for the determination of menadione either in preparations(148), 
feed (149), animal diet and premixes(150) and in feed premixes (151). 
A general test for the analysis of vitamin K,, K3 and K^  in combined 
tablets and injection were separated from their decomposition product 
byTLC(152). Gas chromatography and spectrophotometric methods are 
used to determine vitamin K3 in injection solution or food 
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supplements (153). Thiosemicarbazide has been recommended as a 
reagent for the detection of menadione in pharmaceuticals (154). The 
absbrbance is measured at 540 nm and Beer's law is obeyed in the 
concentration range 4-40 fig/ml. The method proposed is reliable and 
simple. p-Naphthylmethyl ether is used as the internal standard solution 
for gas chromatographic determination of menadione (155). The method 
is simple, fast and accurate with average recovery and relative 
standard deviation of 101% and 1.2%, respectively. 
Differential pusle polarography is used to determine vitamin K3 
In plasma (156). The detection limit is down to a level of 3x10^ 
M vitamin(K3). Another method for the determination of vitamin K3 in 
plasma using differential pulse polarogrpahic technique has been 
described(157). A spectrophotometric method for determining vitamin 
K3 and its sodium adduct in the presence of one another is applied 
successfully at pH 4-7 using phosphate buffer(158). Piperidine and 
malononitrile have been recommended as a reagent for the manual 
and semiautomated spectrophotometric determination of vitamin K3 in 
pharmaceuticals (159). The method is simple and selective. There is no 
interference from vitamin K^  and vitamin K^ . The reaction is sensitive 
enough to permit the detection of 2-100 ng/ml, with an average recovery 
of 98.0% and relative standard deviation of 1.0%. 
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CHAPTER - 2 
Simultaneous Spectrophotometric and Volumetric 
Determinations of Amoxycillin, Ampicillin and Cloxacillin 
in Drug Formulations: Their Reaction Mechanism in The 
Base Catalyzed Hydrolysis Followed by Oxidation with 
lodate in Dilute Acid Solution. 
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Introduction 
A large number of methods for the analysis of ampicillin, cloxacillin, 
amoxycillin and related antibiotics have been described in the literature 
(1-3). Emphasis has been given on spectrophotometric and titrimetric 
methods being simple and easily managable to the third world. The 
volumetric titrations are carried out by some oxidants prior to a base or 
acid catalyzed reaction of antibiotics. The degraded hydrolyzed products 
are prone to oxidants such as Hg (II) (4) and iodate solutions (5) and 
therefore, they are used as titrants. It is interesting to note that when 
hydrolytic conditions are changed from moderate concentration of alkali/ 
acid to a weak or using a selective pH regions (6), a different pathway of 
antibiotics mechanism results. The titrimetric method (4) described by a 
base and enzymatic hydrolysis followed by titration with Hg (II) might suffer 
a setback. The use of nitric acid to neutralize the excess alkali before 
performing the titration may oxidise thiazolidine ring of the penicillin 
molecule and therefore could give erroneous results. The authors 
themselves reported better results with enzyme hydrolysis than base 
hydrolysis. In the direct titration of antibiotics (5), with potassium iodate 
solution strong acidic conditions are prevailed. The acid plays a dual role, 
firstly it brings about acid hydrolysis, secondly it makes the iodate titration 
feasible (Andrews titration). Two procedures have been adopted; one using 
chloroform and the other omitting the chloroform. In the former procedure 
the colour of the chloroform layer changes from colourless to brown or 
deep red to colourless again. In the later one the dye Amaranth is used 
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and the end point is detected by colour changes from deep red to pale 
yellow when the dye Is destroyed by an excess of iodate in aqueous 
medium. These titrations also suffer from certain limitations which have been 
described in the discussion. The determination of amoxycillin and 
flucloxacillin in mixtures and pharmaceutical preparations using 3,5-
dinitrobenzoic acid as reagent is described (7). Extraction and 
spectrophotometric determination of benzylpenicillin is described in 
pharmaceutical preparations, based on the formation of a yellowish red 
colour with potassium iodate in acidic medium (8). The colour is stable for 
about half an hour after its extraction. Beer's law is obeyed in the 
concentration range 0.05-0.5 mg/ml. Another extraction and photometric 
method for benzylpenicillin sodium in a 10% solution potassium nitrate 
containing sulphuric acid at 18-20°C for 3-5 minutes involve a colour 
reaction with 2,3,5 triphenyltetrazolium chloride (9). The coloured product 
is extracted with ethanol having a X 400 nm. A colorimetric method for 
^ max 
the determination of ampicillin and amoxycillin which is based on the 
reaction of oxidant product of ascorbic acid, dehydroascorbic acid with 
the corresponding penicillanic acids obtained by the degradation product 
of the antibiotics after heating under acidic conditions is described (10). 
The major disadvantage of this method is allowing the interference of free 
quantitation of ampicillin and amoxycillin in combination and many other 
substances, like cloxacillin and clavulanic acid. The method shows 
selectivity towards the penicillins having amino acid side chain. A selective 
colorimetric method is described for the analysis of ampicillin utilizing the 
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reaction of ampicillin with p-dimethylaminocinnamaldehycle in the presence 
of tetra-chloroacetic acid in methanol to form a stable red Schiff's base 
(11). The coloured product is detected atX^^^ 501 nm and obeyed Beer's 
law in the range 10-50 ^g/ml. The formation of deep blue complexes is 
utilized for the micro-quantitative determination of ampicillin and cloxacillin 
in pure form, mixture and in pharmaceutical preparations (12). The reaciton 
is carried out with bromothymol blue (BTB) at 25°C and 50°C respectively. 
Beer's law is valid in the concentration range 0.4-18 and 0.4-20 ng/ml of 
ampicillin and cloxacillin, respectively. The determination of amoxycillin and 
flucloxacillin by HPLC in biflocin injection is described (13). The mobile 
phase is a phosphate buffer (pH 6.5). The concentration range is valid 
from 0.25-2 mg/ml. Another HPLC method is carried out for the 
simultaneous determination of ampicillin and dicloxacillin in pharmaceutical 
preparations (14). A complexation between amoxycillin and carbocystein 
with Ni (II) is used for spectrophotometric determination (15). A flow injection 
analysis is described for the determination of amoxycillin and ampicillin 
(16). Potentiometric biosensing of penicillins using a flow-through reactor 
with penicillinase or penicillin amidase immobilised by gamma-irradiation 
is described (17). Titrimetric method for the assay of selected antibiotics 
in non-aqueous media is carried out by conductometric titration (18). A 
spectrophotometric method for simultaneous determination of amoxycillin 
and dicloxacillin in pharmaceutical preparations is described (19). The 
assay of ampicillin in the presence of cloxacillin in pharmaceutical 
preparations involves the reaction of hydrolyzed ampicillin with formaldehyde 
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in acidic phosphate and subsequent measurements of the absorbance at 
373 nm is described (20). Copper (II) acetate has been used as a 
complexing agent for the spectrophotometric determination of benzyl-
penicillin in pharmaceutical preparations (21). 
In this chapter, we describe basic hydrolysis of antibiotics in dilute 
solution of sodium hydroxide. The degraded products are titrated with 
potassium iodate using a dilute solution of the acid. As far our knowledge 
is concerned a very few determinations have been made in this 
direction, contrary to the proposed reactions in concentrated acid. The 
feasibility of such titrations with reaction chemistry has been discussed 
in a simple and logic way. The results of this titrimetric have been 
compared with spectrophotometric method. The oxidation mechanism of 
degraded products of antibiotics has been proposed in the light of IR, TLC 
and spectrophotometric analysis. 
EXPERIMENTAL 
Apparatus 
A Bausch and Lomb spectronic - 20 D* and Spectronic-1001 (split-
beams. Milton Roy Co.), with 1-cm path length quartz cells were used. 
A controlled water bath to maintain the required temperature (NSW-133, 
India). IR spectra of the isolated products were recorded on a (Shimadzu 
IR-408, Japan) with KBr disc. 
Reagents and solutions 
Standard solutions of antibiotics. These were prepared freshly by 
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dissolving the appropriate amount of each antibiotic in water to provide 
1 mg/ml solutions of antibiotics. The standard solutions must be stored in 
a well-dark closed container to avoid direct contact with light. 0.1 M 
potassium iodate, 1.0 M hydrochloric acid and 0.1 M sodium hydroxide, 
were prepared freshly with double distilled water. All other chemicals used 
were of analytical and pharmaceutical grade. 
General Procedure 
Procedure (I): Simultaneous determination of penicillins by volumetric 
titration against potassium iodate and spectrophotometry of coloured 
complex in organic layer. 
Allquots of 2.5 ml of 0.1 M sodium hydroxide were added into a 
conical flasks. Suitable volumes of each of the standard penicillins 
solutions, containing between 0.2-2.0 mg/ml of amoxycillin and ampicillin 
and 0.1-2.5 mg/ml of cloxacillin, were added to each of the conical flasks. 
The solution was mixed by shaking and then placed for 10-15 min in a 
water-bath thermostated at 80.0°C. After completion of the heat treatment, 
the solution was cooled to room temperature, then 0.5 ml of 1.0 M hydrochloric 
acid and 5 ml carbon tetrachloride were added. The contents were titrated 
against potassium iodate. The end point was detected by change from 
colourless to deep red colour in organic layer. For spectrophotometric 
determination, the organic layer was removed in a 50 ml separating 
funnel, dried over anhydrous sodium sulphate and measured absorbance 
at 520 nm against a blank. 
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Procedure (II) : Determination of penicillins by spectrophotometric 
method 
To a known volume of amoxycillin solution ranging between (0.4-
3.5), ampicillin (0.4-2.8) and cloxacillin (0.1-2.5), 2.5 ml of sodium 
hydroxide were added in a boiling test tube. The reaction mixture was 
kept for 10-15 min. on a water bath at 80.0°C. After cooling to room 
temperature, 1 ml of potassium iodate, and 0.5 ml of hydrochloric acid were 
added to the reaction mixture. The solution was shaken with 5 ml carbon 
tetrachloride, till a deep red colour in organic layer was extracted and 
followed the above procedure I. 
Assay of formulations 
For the determination of penicillins in tablets and capsules, the 
above methods were applied with no modification. Approximately 4-5 tablets 
were grinded into finely divided powder. A 100 mg of it was accurately 
weighed and transferred into a 100 ml standard flask. Similarly the 
contents of capsules were weighed and dissolved equivalent to 100 mg 
in 0.1 litre. The solution was well shaken for about 30 minutes to ensure 
a homogeneous solution. The residue was removed through a Whatman 
No. 1 filter paper and the washings were taken into the final volume i.e. 
0.1 litre. 
RESULTS AND DISCUSSION 
The mechanism of penicillins in 0.1 M sodium hydroxide resulting in 
different degraded products can be rationalized in the light of I.R., U.V. 
spectroscopic, TLC and molar stoichiometries molar ratio of iodate to 
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penicillin titration. The possible degradation pathways are illustrated in 
(Fig. 2.1). 
TLC and spectrophotometric observations 
The presence of (la) has been suggested on the basis of the 
results obtained by T.L.C. (R, = 0.46 in a solvent system, 66% n-butanol, 
17% glacial acetic acid, 17% water). This observation is in agreement with 
previous studies (6), confirming the existence of 4-hydroxymethylene 
oxazolone (la), (R, = 0.42 in the same solvent). Moreover the product (la) is 
isolated in the region of pH 13-14, showing a product yield 24% and 
76%, with U.V. spectroscopic quantitative analysis; X^^^ 295 nm and log 
8 = 4.23. Our studies of hydrolysis in 0.1 M NaOH at pH~13 involving a 
single step reaction using water bath at 80°C, show one X^^^ 240 nm, 
at reaction time 15min. On extending the time-interval to 12 hr, another 
l^^^ 270 nm is obtained attributing to the existence of lb(i), (ii), (iii) and 
1(a), respectively. The establishment of lb(i) or lb(ii)/lb(iii) could not 
be proved by T.L.C. as it is confirmed earlier (6) being degradated product 
in the pH range 4.0-13.0 with T.L.C. results of R, = 0.46 in the solvent 
system, 66% n-butanol, 17% glacial acetic acid, 17% water. However, the 
formation of penicilloic acid lb (i) from basic hydrolysis of Penicillin is well 
established (22). 
IR Studies 
Three different spectra were taken, (i) pure amoxycillin, spectrum-A 
(Fig. 2.2) (ii) degraded in base catalyzed hydrolysis, spectrum-B (Fig. 
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2.3) (iii) degraded base hydrolyzed treated with 1.0 M hydrochloric acid, 
followed by titration against KIO3, spectrum-C (Fig. 2.4). 
The spectrum (B), compared with spectrum (A), revealed that the 
characteristic bands for different groups at specified frequencies in 
spectrum (A) are found (i) missing, (ii) formation at different frequencies 
or (iii) remained unchanged. They are discussed as follows: A broad flat 
portion (3450-2600 cm-^) same as it is found in spectrum (A), attributed 
to primary aliphatic amine N-H (3450-3250 cm""), carboxylic (3300-2500 
cm-^ ) and S-H (2600-2500 cm"^ ) groupings. 
Missing and formation of new bands 
The bands are found missing in the range (1800-1500 cm-^ ) and 
(1350-1000 cm"") resulting the formation of bands at 860 cm\680cm^ 
and in the range (1500-1350 cm-^). The identities of thiozolidine and 
secondary amine groups with different group frequencies lying in the 
range 1800-1510 cm-^  are completely swept out. The second range of 
missing band (1350-1000 cm-^ ) includes the groups e.g. CH3-S, ester etc. 
The two missing ranges are revealed by a descending and ascending 
portion of spectra-B respectively. The formation of a broad band (1500-
1350cm-^) is attributed to the presence of 4-hydroxymethylene oxazolone 
(la), which is revealed by the groups frequencies C-0 stretching and 
0-H deformation vibration (1440-1395cm-^). The ascending portion (1350 
cm-^  onward) of spectrum (B) further describes the hydrolysis of the rest 
of groups present, resulting more stable products. A strong peak at 860 
cm-^  may be attributed to -S-0 (870-810 cm-^ ) of sulphonic acid. The 
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weak peak at 680 cm"^  suggests to disulphide -S-S, C-S (705-570 cm^)ancl 
sulphoxide (>S=0, C-S-0 at 730-690 cm^) after their partial oxidation to 
sulphonic acid in a semiquantitatively manner as the sulphur compounds 
especially containing the group S-H, S-S, are oxidized by mild oxidant or 
even atmospheric oxygen (23). The spectrum (C), which is obtained after 
completing the titration against iodate in dilute acidic conditions, gave the 
final product corresponding to strong peak at 835 c m \ attributed to the 
presence of sulphonic acid quantitatively. 
The recommended procedure (I) describes simultaneous volumetric 
determination of penicillin against potassium iodate as oxidant in dilute 
acidic medium. The deep-violet colour extracted in carbon tetrachloride at 
the equivalent point is also studied spectrophotometrically. The hydrolysis 
products of penicillins (amoxycillin, ampicillin and cloxacillin) which 
contained sulphur derivatives i.e. -C-S-C groups (la), -S-H groups (lib) are 
quantitatively oxidized to some Intermediate species and finally to sulphonic 
acid whose identities have already been discussed in IR studies. The 
hydrolysis by dilute sodium hydroxide solution (0.25 m moles, pH 13) has 
been carried out slowly at a constant temperature (80.0°C) with 
intermittence shaking. The excess of base is neutralized by adding 
hydrochloric acid (0.5 m moles) so that the reaction mixture attains a pH 
2 2. This provides a conductive environment of H3O* concentration for 
carrying out the titration of degradation products against oxidant potassium 
Iodate. The reaction is summarized as follows: 
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HS-R+3H,0 
6e-
lO; + CI + 6H* + 4e-
•^  RSO3H + 6H* + 6e-] X 2 
)> ICI + 3H30]x3 
I step 
reaction 
In the first step reaction a quantitative oxidation of thiol to sulphonic acid 
followed by reduction of IO-3 to ICI take place which may be regarded 
as the reaction at equivalent point, but without any colour change. This 
shows that theoretically calculated value of stoichiometry should be of 2 
mol of thiol group to 3 mol iodate (1:1.5) which is inconsistent with 
experimental value i.e. 1:2. Still the system involves more iodate ions to make 
the end point visible due to its reduction to iodine monochloride and finally 
to free iodine which is described in II step reaction given below: 
reduction 
IO3 + 6H* + CI + 4e- • ICI + 3H2O 
dissociation 
ICI y r + CI 
hydrolysis 
l^  + H^ O — — • HOI + H* 
5H0I 
Over consumption 
of iodate 
: ^ 2I2 + IO3 + H* + 2H2O 
llnd step 
reaction 
In the II step reaction an overconsumption of iodate takes place (24), 
thereby increasing the mole ratio of iodate from 1.5 to 2 mol which is 
consistent with the experimentally observed stoichiometry of 1 mol thiol to 2 
mol iodate. A stable red violet colour in organic layer due to the formation 
of free iodine is the indication of equivalent point. The epsilon (E) for 
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amoxycillin, ampicillin and cloxacillin are calculated 0.4141 x10^ 0.8385 x 
102 and 1.5668 x 10^ I moM cm \ respectively. 
For spectrophotometric determination, the absorbance of red violet 
colour is measured at X 520 nm. The results are summarized in Tables 
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2.1(A), 2.1(B); 2.11(A), 2.11(B); and 2.111(A) , 2.111(B). The recommended 
procedure II is done exclusively for spectrophotometric determination and 
to compare the results of procedure I. The results are summarized in Table 
2.1(C), 3.11(C) and 2.111(C). 
In Andrews titration, a strong hydrocholric acid (3-9M) solution is 
required for quantitative of iodate to iodine monochloride complex (ICI^) 
as given below: 
IO3 + 6H* + 2Cr + 4e" • ICf^  + 3H2O E ° = 1.23 V 
However, if the concentration of hydrochloric acid at the end point is 
atleast 3M, iodate reacts quantitatively with reducing agents such asKI, 
Ij, ASjOg, NjH^ and SO^ to form iodine monochloride (25), in many other 
cases the concentration of hydrochloric acid is not critical, but for Sb(lll), 
it is 2.5-3.5 M that is the optimum acidity for reasonably rapid reaction 
varies from one reductant to another reductant (26). Using a dilute 
hydrochloric acid as described by the recommended procedure I, still a 
quantitative reduction of iodate to free iodine is feasible because the 
degraded products of antibiotics contain sulphur derivatives which can be 
oxidized by a very mild oxidizing agents(23).Thehalf reaction of iodate in 
dilute acid solution E° (25) can be proposed as under: 
2IO"3 + 12H* +10e- • I2 + 6H2O E°= 1.19 V 
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The method described earlier (5) for the direct titration of antibiotics 
by lodate solution in a high concentration of acid (12 mo! dnr^) is based 
on Andrew's method. The reduction of iodate to iodine mono-chloride 
complex involving electron change of four and oxidation of thiol group (from 
penicillamine (IV) to the sulphonic acid (VI) and that of (aldehyde from 
penilloaldehyde (III)) to the carboxylic acid (V) accompanied with electron 
changes of six and two respectively. The overall stoichiometry has been 
computed by summing up the two different oxidation products with a 
total electron change of eight which is consistent with their experimental 
stoichiometric ratio 2 mol iodate and 1 mol penicillin. This is revealed by 
the following reaction: 
Penicillin + [V] + [VI] + 8e" 
l03'+6H* + 2 C r + 4e" > ICi; + 3H20]x2 
However, if the above oxidation reduction is considered separately 
it reflects a different aspect as given below: 
H - S(IV) • HO3S - (VI) + 6e-] X 2 
10-3 + 4e- • ICi ; ] X 3 (i) 
-CHO (III) •COOH (V) + 2e"] x 2 
l03 + 4e" • I C g x 1 (ii) 
In reaction (i), the stoichiometry of 2 mol penicillin/H-S to 3 mol 
iodate and in (ii)2molpenicillin/-CHOto 1 moliodate are observed, which is 
inconsistent with their experimentally stoichiometric ratio of iodate to penicillin 
2 : 1 . 
In the introductory part the authors have stated that "the iodate not 
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only oxidized the iodine produced by the reduction of iodine mono-
chloride (non aqueous), but further oxidized the sulphoxide produced in this 
reaction to sulphonic acid (aqueous). Addition of these two titrations results 
produced the overall experimentally stoichiometry, 1 mol of penicillin to 
2 mol of iodate". The conclusion of this statement has been completely 
overlooked in the discussion part. We have tried to elaborate the above 
reaction system taking place in two fold manner that is the potassium 
iodate is reduced to iodine monochloride in the presence of a high 
concentration of acid (12 mol dm''). During the course of titration as long 
as the reductant is present in the system, iodine monochloride further 
reduced to free iodine. This stage of titration can be regarded as the first 
stage, when equivalence point can be declared theoretically which 
immediately vanishes due to further reaction of iodine with iodate. The 
second stage of titration of iodate is started with free iodine to yield iodine 
monochloride complex, the disappearnce of deep red violet to colourless 
resulting the declaration of equivalence point followed by an 
overconsumption of iodate which increases the number of the moles of 
iodate to approximately to experimental value. 
To study the optimum conditions relating intensity and stability of 
colour, variation of temperature and effect of adding volume of reagents 
are summarized as follows: 
Effect of time and temperature 
The colour formed was found stable when the temperature range 
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80-90°C, during time interval of 10 minutes. The absorbance (X^^^ 520 nm) 
remained constant but started decreasing on increasing the temperature 
to 100°C (Figs. 2.5 and 2.6). 
Effect of adding reagents 
(i) Sodium hydroxide (ii) potassium iodate (iii) hydrochloric acid. The 
volumes at which the absorbances was found with optimum values are 
given below: 
(1) 0.1 M sodium hydroxide, 2.5 ml (Fig. 2.7) 
(2) 0.1 M potassium iodate, 1 ml (Fig. 2.8) 
(3) 1.0 M hydrochloric acid, 0.5 ml (Fig. 2.9). 
Absorption spectra 
The absorption spectra of the reaction products are shown in 
Fig. 2.10. 
Calibration graphs: 
Beer's law holds good for the following concentration ranges of the 
three antibiotics (Figs. 2.11,2.12 and 2.13). 
(1) 
(2) 
(3) 
Penicillins 
Ampicillin 
(mg/ml) 
Amoxycillin 
(mg/ml) 
Cloxacillin 
(mg/ml) 
Concentration range 
0.1-2.0 (a) 
0.04-0.4 (b) 
0.04-0.56 (c) 
0.1-2.0 (a) 
0.04-0.4 (b) 
0.08-0.7 (c) 
0.1-2.5 (a) 
0.02-0.5 (b) 
0.04-0.5(c) 
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The effect of the interfering substances in the determination of 
penicillins are shown in Table 2.1V. This study shows the maximum tolerance 
of interfering substances in the minimum amount of penicillin. 
Applications 
The validity of the proposed method was tested by successive 
determinations of penicillins in pharmaceutical preparations. The results 
obtained by the recommended methods are presented in Table 2.V, and 
compared with reference standard methods. 
Statistical Approach 
The treatment of analytical data using statistical approach for the 
determination of amoxycillin, ampicillin and cloxacillin using different 
concentrations have been presented In Table 2.VI. The best straight lines 
equations with variable x and y and incorporating the slope and intercepts 
for each antibiotic are computed. They have been drawn graphically to 
showthe best true mean values (Figs. 2.14,2.15and 2.16). 
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Fig. 2.1 Thepossibledegradationpathwaysof penicillin. 
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Fig. 2.7 Effect of varying volume of 
sodium hydroxide, at 80°C. 
(A)amoxyciilin; (B) ampicillin; 
(C) doxacillin 
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Fig.2.8 Effect of varying volume of 
potassium iodate, at 80°C. 
(A)amoxycillin: (B) ampicillin; 
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Fig.2.9 Effect of varying volume of 
hydrochloric acid, at 80°C. 
(A) amoxycillin; (B) ampicillin; 
(C) doxacillin 
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Fig.2.10Absorption spectra of the reaction products of 
penicillins, at 80»C. (A) amoxycillin; (B) ampicillin; 
(C) cloxacillin 
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Fig. 2.13 Calibration curves of amoxycillin(a); ampicillin(b) and cloxacillin(c) 
in reference with Tables 2.1(C), 2.11(C) and 2.111(C) 
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Fig.2.16 Best straight line equation in the determination of 
amoxycillin (a), ampicillin (b), cloxacillin (c) in reference 
with Tables 2.1(C), 2.il(C) and 2.111(C) 
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CHAPTER - 3 
Spectrophotometric Determination of Thyroxine 
Sodium in Drug Formulations. 
J 
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Introduction 
The assay of thyroxine sodium is carried out using oxygen combustion 
flask (1) and iodometric methods (2). These two methods are specific for 
levothyroxine and based on the assumption that the active ingredient consist 
of only the levoisomers. The use of chromatographic method is neccessary 
for separation of the levoisomers from other isomers and the decomposition 
product. The levothyroxine has been quantitatively determined by 
colorimetric method, using 2,4,6-trinitrobenzene sulphonic acid as colouring 
agent (3). The method involves the reaction at 18°C in subdued light. The 
resulted yellow coloured complex is extracted in isobutylmethylketone.the 
extracted thyroxine sodium is determined at X^^^ 423 nm. In another 
reaction, the coloured product of thyroxine sodium with p-benzoquinone is 
formed and estimated spectrophotometrically (4). Beer's law is obeyed over 
the concentration range 40-200 ^g mM when applied to tablets. A colorimetric 
immunoassay based on enzyme activity inhibitor is described (5). The 
homogeneous enzyme immunoassay of thyroxine and tri-iodothyronine is 
performed using glucose-6-phosphate dehydrogenase (6). A procedure for 
the determination of thyroid hormones in pharmaceutical preparations by 
titration with silver nitrate and simultaneous use of iodine selective electrode 
is described (7). The method is applicable to content uniformity analysis as 
well as to bulk material and to the determination of iodide in other 
pharmaceutical preparations such as sodium levothyroxine tablets. The 
method Is recommended for routine quality control use. A thin layer 
chromatographic method is developed for the determination of thyroxine, tri-
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iodothyronine and iodide in a mixture(8).The elution mixture of butanol-ethanol-
2M ammonia and isoamylalcohol-2M ammonia are used for the separation 
of iodine 125. Gas chromatography-mass spectrometry are used to analyze 
thyroid hormones (9), as their hepta fluorobutyrylmethyiester derivatives. 
Levothyroxine sodium is determined in tablets by reversed-phase high 
performance liquid chromatography (10). The method can be used for 
determining content uniformity and dissolution of levothyroxine in tablets. 
Gas chromatogrpahic method has been used for trace analysis of thyroid 
hormone preparations and drugs containing thryoid hormones (11). The 
method is suited for purity control of thyroid hormone preparations as 
well as for trace analysis of iodoamino acid in drugs containing thyroid 
hormones. The isolation of iodoamino acid from accompanying substances 
containing thyroid hormones is developed using ion exchangers on the 
basis of their sorption behaviour. Another method has been developed for 
the analysis of thyroid hormonal compound using fast derivatizatlon gas 
chromatographic technique (12). The procedure is based on a cooperative 
action of two reagents, dichlorotetrafluoroacetone and a perhalogenated 
anhydride, on the hydrogen - containing groups in the iodo compounds. The 
procedure Is suitable for derivatizatlon of the deamination and decarboxylation 
products of the lodothyronines i.e., for triac and tetrac. The use of capillary 
gas chromatography with electron-capture detection is applied successfully for 
the analysis of Iodothyronine (13). The method shows a good precision within-
day for the temperature-programmed analysis of derlvatized lodothyronines 
at the low picogram level under practically operating conditions. A highly 
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sensitive electron capturing standard is also used for detern^iining the thyroid 
hormones (14). The method is based on the use of 2-methyl-naphthalene-
bis (hexachlorocyclopentadiene) adduct, which serves as a precursor to 
substituted naphthalenes, and gel filtration chromatography, using a sephadex 
LH-20 column for the separation of thyroidaliodoamino acids (15). The 
reduction of thyroxine, liothyronine, diiodothyronine, diiodotyrosine and 
monoiodotyrosine has been studied using silver rotating disk electrodes in 0.10 
M sodium hydroxide (16). The use of a carbon electrode as an electrochemical 
HPLC detector for thyroxine has been described (17). A simple chromatographic 
method has been applied for the isolation and separation of thyroxine from 
the blood serum (18). The analysis and clinical performance of thyroid is 
assessed by using radioimmunoassays with antibodies attacked to 
paramagnetic micro-particles (19). Many other analytical techniques have been 
described in the literature for the determination of thyroxine and related thyroid 
hormones which include fluorimetry (20), Gas chromatography (21-23), thin 
layer chromatography (24) and high performance liquid chromatography (25-
26). 
The present chapter describes the spectrophotometric determination 
of thyroxine sodium which is based on interaction of its amine group with 
nitrous acid to produce a yellow coloured product at a cooling bath (0-5°C). 
EXPERIMENTAL 
Reagents and apparatus 
A1 mg/ml solution of pure thyroxine sodium (Glaxo, India) was 
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prepared in ethanol-dimethyl sulphoxide (DMSO) mixture (1:1, v/v). A1.0M 
solution of sodium nitrite, and 1.5 M hydrochloric acid were prepared in 
distilled water freshly. All other chemicals used were of analytical grade. 
Eltroxine tablets (Glaxo, India) one tablet of eltroxine weighing on an average 
0.1504 gm, contains 100 ng of thyroxine sodium as reported on its label. 
Thyrox tablets (Madeods Pharmaceutical, India) one tablet of thyrox 
weighing on an average 0.105 gm, contains 50 ^g of thyroxine sodium as 
reported on its label. 
Procedure 
To a preceded mixture (temperature range 0-5°C) of 1 ml hydrochloric 
acid and 1 ml of sodium nitrite is added an accurately measured volume 
of thyroxine sodium (0.1-0.9 ml) and diluted upto the mark of a 10 
ml volumetric flask with ethanol-DMSO (1:1) mixture. The contents of the flasks 
are allowed to stand for 20 minutes in ice-cold bath (0-5°C) in order 
to complete the reaction during which time a stable yellow coloured product 
is formed. The absorbance of coloured product is measured against a 
reagent blank at X 420 nm (Fig. 3.1). 
Assay of thyroxine sodium tablets 
Eltroxine 
10 eltroxine tablets are accurately weighed, crushed into a finely 
divided powder, and dissolved in ethanol-DMSO (1:1,v/v). The undissolved 
portion is removed by filtering through a Whatman No. 1 and diluted upto 
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the mark in a 10 ml volumetric flask, and then follow the recommended 
procedure for its determination. 
Thyrox 
Weigh out accurately 20 thyrox tablets, and follow the preparation 
as mentioned for eltroxine. 
RESULTS AND DISCUSSION 
Nitrous acid has proved to be a useful reagent for the determination 
of amines and amino acids. The reaction is carried out by adding aqueous 
solution of sodium nitrite to an ice-cooled aqueous solution of amine or amino 
acid in the presence of dilute mineral acid (27). Thyroxine sodium with 
systematic names, sodium L-3-[4-(4-hydroxy-3, 5-diiodophenoxy)-3,5-
diiodophenyl] alanine or sodium L-3,3', 5,5'-tetraiodothyronine, is the 
levoisomer of thyroxine. The structural formula of thyroxine sodium is given 
in Fig. 3.2. 
0 0 No 
Fig. 3.2 Thyroxin Sodium 
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The reaction of thryoxine sodium with nitrous acid involves the possible 
kinetic mechanism of aliphatic primary amine (-NHj group), resulting in the 
formation of extremely unstable pale yellow nitrosoamine under experimental 
conditions. The product is made stable and quantitative by using mixed 
solvent system, ethanol : DMSO (1:1, v/v). This system has been found 
advantageous is increasing the molar extinction coefficient, stability of the 
coloured product and colour intensity compare to the solvent system water, 
ethanol and dioxane. The effect of solvent system on aromatic nitro 
compounds-base complexes has been reported and found that the solvent 
effect increases many fold on the equilibrium constant (K), heat of 
formation, and the molar extinction coefficient on changing the medium 
from methanol to acetone or to dimethyl sulphoxide (28). One more example 
of the use of dimethyl sulphoxide has been described in the detection of nitro 
compounds where the sensitivity of identification increases tremendously 
(29). 
Nitrous acid is unstable and is usually prepared by mixing of 
freshly prepared solution of sodium nitrite with appropriate concentration 
of hydrochloric acid in an ice cooled bath. These conditions provide a 
© 
source of : N=0, which is transferred readily to the nucleophilic nitrogen of 
amine. 
MONO + \?, ^ H,0 + : N = O 
1^ (^J) I© .. 
- N : + : N = O > — N— N = O 
I I 
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The formation of yellow colour may be explained in terms of diazotization 
of the -NHj group of thyroxine sodium in the presence of nitrous acid 
yielding a diazonium salt which may be cyclized to give a five-membered 
heterocyclic ring. The reaction mechanism of the pale yellow coloured 
product has been tentatively summarized in the reaction scheme (Fig. 
3.3). 
Study of the proposed experimental conditions 
To obtain the optimum conditions, the effect of different volumes of 
HCI and NaNOj was studied. It is found that a volume of 1.0 ml of 1.5 M 
HCI (Fig. 3.4) and 1.0 ml of 0.1 M NaNOj (Fig. 3.5) gave optimum results 
for0.5mg of thyroxine sodium. Under the optimum experimental conditions 
the product is found to be stable after 20 minutes (Fig. 3.6) in an ice cold 
bath (0-5°C). Beer's law is obeyed in the concentration range of 10-90 pg 
mj-^  of thyroxine sodium (Fig. 3.7) at A420nm with apparent molar absorptivity 
of 4.0x103LmoMcm^ 
To test the validity of the recommended procedure 12 replicate 
samples, each containing 50ng m l \ 40pgmM, 20}igmM and 90)igmM 
of thyroxine sodium in the final solution are run. At these concentration levels, 
the mean standard deviation and mean relative standard deviation are 0.48 
and 1.14, respectively. The results are summarized in Table 3.1. Standard 
addition technique was also carried out to analyse the thyroxine sodium 
(Table 3.2). The diverse ions effect of various ingredients used in the 
preparation of tablets and their maximum tolerance (mg), are recorded in 
Table 3.3. 
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A Statistical treatment of data obtained by recommended method and 
the official BP 1980 procedure is presented in Table 3.1. 
The calculated "F" and "t" test values are found to be 1.03 and 0.99, 
respectively, and these values are relatively smaller as compared to the 
theoretical values, which suggested that there is no significant difference 
between the two methods in terms of precision and accuracy. 
The recommended method was found rapid, simple and suitable for 
routine analysis of thyroxine sodium tablets in drug formulation and 
pharmaceutical preparations. 
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Table 3.1. Statistical treatment of data obtained by recommended 
method and BP 1980 procedure. 
Computation of standard deviation (SD ^ig/mi) and relative standard 
deviation (RSD%) in a set of three determinations of thyroxine sodium. 
Mean, % recovery 
+ RSD,% 
Procedure 
Recommended 
99.45% 
1.24 
BP1980 
99.81% 
1.22 
Thyroxine Sodium 
Taken 
figm\^ 
20.0 
40.0 
50.0 
90.0 
Found 
//gmi-^ 
20.0 
20.0 
19.5 
40.0 
40.0 
41.0 
49.0 
50.0 
50.0 
90.0 
90.0 
89.0 
SD, 
(^g/ml) 
0.29 
0.58 
0.49 
0.58 
RSD, 
(%) 
1.47 
1.45 
0.98 
0.65 
Mean standard deviation = 0.48/^g/ml 
Mean relative standard deviation = 1.14% 
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Table 3.2 
Analysis of thyroxine sodium in tablets using standard addition technique 
Sample 
Eltroxine 
Thyrox 
Claimed 
amount 
taken 
(mg) 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
Authentic 
added 
(mg) 
0.1 
0.3 
0.5 
0.7 
Total 
found* 
(mg) 
2.00 
2.10 
2.30 
2.49 
2.69 
Mean % recovery 
-
0.4 
0.6 
0.2 
0.1 
2.0 
2.395 
2.61 
2.198 
2.10 
Mean % recovery 
%, Recovery 
of added 
_ 
100.0 
100.0 
98.0 
98.6 
99.15 
-
98.75 
101.7 
98.5 
100.0 
99.74 
*Average of three different experiments. 
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Table 3.3 
Maximum tolerance of foreign substances in the estimation of thyroxine 
sodium (50//g/ml) 
S.No. 
1. 
2. 
3. 
4. 
5. 
6. 
Foreign substances 
Glucose 
Lactose 
Fructose 
Sucrose 
Ca2* 
co/-
Maximum tolerance 
(mg) 
32.43 
72.46 
36.43 
68.46 
8.01 
12.00 
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390 420 
Wove l e n g t h ( n m ) 
490 
Fig. 3.1 Absorption spectrum of thyroxine sodium reaction 
product against a reagent bianlc at a cooling 
temperature ranging 0-5'>C. 
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Fig. 3.7 Calibration curve of thyroxine sodium, at a 
cooling temperature ranging (O-S^C); A.^ ,^  = 
420 nm. 
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CHAPTER - 4 
Ultraviolet Spectrophotometric Determination 
of Trimethoprim in Tablets and Oral Suspension 
Prior to its Separation from Sulphamethoxazole 
by TLC. 
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Introduction 
Trimethoprim ( t r imethopr im; TMP) in combinat ion with 
sulphamethoxazole (sulphamethoxazole; SMX) is a highly effective broad 
spectrum chemotherapeutic formulation (1). Several high-performance 
liquid chromatographic (HPLC) assay methods for TMP, SMX and other 
related sulphonamides in dosage forms and pure drugs, have been 
described (2-6). HPLC method is adopted for the simultaneous 
determination of TMP and SMX in serum and urine (7). The separation is 
achieved on a reverse-phase column employing acetic acid-methanol 
as a mobile phase with spectrophotometric detection at 230 nm. 
Determination of trimethoprim and sulphamethoxazole in pharmaceutical 
dosage form has been described using high-performance thin-layer 
chromatographic techniques (8). A densitometric and a spectro-
photometric method for rapid and accurate determination of SMX and TMP 
is described in combined dosage form (9). Another TLC-densitometric 
method for simultaneous determination of sulphonamides and TMP in 
dosage forms is also mentioned (10). The method is suitable for checking 
the identity of the active substance and for quantitative evaluation of 
sulphonamides and TMP. A large number of methods based on HPLC, gas 
chromatography and potentiometry for the determination of TMP and its 
degradation products in pharmaceutical preparations, biological fluids, 
and serum have been mentioned in the literature (11-21). 
The electrode selective for TMP is based on the ion-pair complex of 
TMP with silicotungstate film. Cyclic voitammetry and differential pulse 
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polarographic techniques are used to describe the electrochemical 
behaviour of TMP. The optimum conditions for the determination of TMP 
concentration ranges from 5.5 x 10^ - 5.5 x 10-^ mol 1^  (22). 
Spectrophotometric methods continue to enjoy its popularity among 
other methods, especially for laboratory having limited resources.A tri-
wavelength UV-spectrophotometry is used for the simultaneous 
determination of cephalexin and trimethoprim in capsules (23). Another 
spectrophotometric method for the simultaneous determination of TMP 
and sulphadiazine in combined dosage forms is described (24). Kalman 
filter spectrophotometry for the determination of SMX, TMP and 
sulphadiazine is based on dissolving the capsules in ethanol, diluting 
with acid and measuring absorbance with filter of wavelength range 
220-330 nm (25). Direct spectrophotometric quantitative determinations 
of TMP and SMX are achieved using sodium hydroxide (0.1 M) as a 
solvent for TMP and SMX with A^3^256 and 288 nm, respectively (26). 
Another spectrophotometric method has been reported for the 
simultaneous determination of TMP and SMX in combined dosage 
forms in the UV region (27-28). A spectrophotometric method for the 
determination of TMP and SMX in pharmaceutical preparations using 
the absorbance difference technique at 247 nm and 290 nm for SMX 
and TMP, respectively, has been described (29). Another spectrophoto-
metric method has been carried out for the determination of SMX and 
TMP in cotrimoxazole tablets (30). Chloranil in dioxane is used as a 
colouring reagent for the spectrophotometric determination of TMP in 
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pharmaceutical dosage forms (31). The interference caused by SMX is 
avoided by extraction of TMP in chloroform layer. Spectrophotometric 
determination of TMP in tablet (containing SMX) is based on the 
formation of a pink coloured charge-transfer complex of TMP with 
chloranilic acid. The reaction of SMX with chloranilic acid is found 
negative (32). 
The present chapter describes the spectrophotometric determi-
nation of trimethoprim in tablets and oral suspension which are 
available in combination with sulphamethoxazole. The recommended 
procedure describes a quantitative UV spectrophotometric determi-
nation of sulphamethoxazole prior its separation by TLC. The 
concentrated zone of TMP is scrapped carefully and extracted in 90% 
aqueous ethanol followed by the recommended procedure for 
measuring the absorbance of yellow coloured compound at 355 nm. 
EXPERIMENTAL 
Reagents 
A 1mg/ml solution of pure trimethoprim (Himedia Lab. India) was 
prepared in distilled ethanol. 0.1 mol/l potassium peroxydisulphate 
(freshly prepared) and 0.1 mol/l sodium carbonate solution were 
prepared in distilled water. The other chemicals used were of analytical 
grade. 
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Apparatus 
Absorption spectra and absorbance were measured on a Bausch 
and Lomb spectronic-20, using 1-cm matched quartz cell. A water bath 
with shaker (NSW-133) was used to control the temperature (100°C) 
duiingthe heat treatment and the colour development. 
Test Solution 
A 1 mg/ml trimethoprim solution was prepared in distilled ethanol. 
The tablets and oral suspensions were purchased from local market. 
The solutions were also prepared immediately before use. 
Procedure 
Preparation of calibration graph 
Aliquots of 0.1-0.6 ml of the standard solution are pipetted into 
a series of 10 ml volumetric flasks. Optimum results are obtained after 
addition of 2.8 ml of potassium persulphate and 3.8 ml of sodium 
carbonate. The solutions are heated on a water bath at a temperature 
100°C for 30 min. to complete the reaction. After cooling to room 
temperature and dilution to 10 ml with distilled water, the absorbance 
of the yellow coloured solution is measured against a reagent blank 
at k^^^ 355 nm (Fig. 4.1). Beer's law is obeyed at the concentration 
range 10-60//g/ml. 
Application of the proposed method 
The proposed method is used for the estimation of trimethoprim 
in tablets and oral suspensions. A comparative study by a reference 
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method is also performed. One tablet is accurately weighed, crushed 
to finely divided powder, and dissolved in ethanol. The undissolved 
portion is removed by filtration and the filtrate is collected in a 10 ml 
volumetric flask. A 0.10 ml of oral suspension is pipetted out (equivalent 
to 80 mg of trimethoprim), dissolved in 10 ml ethanol, and then followed 
the above procedure. 
Thin layer chromatography 
Aliquot of 0.01 ml of each standard drug solutions of TMP and SMX 
are applied 3n the silica gel plate with a microsyringe and the plates 
are developed by the ascending technique. A mixture of carbon 
tetrachloride, acetone (6:4) ratio is used as mobile phase. The appearance 
of spots at different positions are located by iodine vapours and 
the R^  of trimethoprim is compared against the R, (ranges from 0.20 
to 0.23) of pure TMP under the same conditions. The regions containing 
the respective TMP are scrapped from the plate and eluted with 90% 
aqueous ethanol. The TMP contents are then determined 
spectrophotometrically by the recommended method. 
RESULTS AND DISCUSSION 
Peroxydisulphate in the presence of sodium carbonate may undergo the 
following reactions producing sulphate and bicarbonate radicals anions 
which is parallel to the reaction between persulphate and bisulphate 
ions (33). A tentative mechanism is proposed as follow : 
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Na,C03 
Moisture 
-> NaHC03+NaOH 
S,03+HC03 
Persul- Bicarbonate 
phate 
ion 
ion 
-» [SOJ- + s o , + [HOG,]-
Sulphate Sulphate Bicarbonate 
radical 
anion 
ion radical 
anion 
The above radical anions [SO'J/fHCOgJ may bring about the oxidation 
of aromatic amino groups to the yellow coloured nitroso compound. This 
reaction may be considered as a parallel conversion accomplished by 
Caro's acid (H^SO^) for the oxidation of primary aromatic amine (34) 
(Fig. 4.2). 
M«0 
M*0 
MeO 
NH2 
RodicolS 
onions 
NH2 
Trimethoprim 
M*0 
M«0 
MtO 
O 
Nitroso Compound 
Fig. 4.2 Reaction mechanism of trimethoprim with persulphate 
The sulphamethoxazole [SMX] also contains one primary aromatic amine 
and therefore there is equal probability of having oxidized to nitroso 
compound. The interference of SMX in the determination of TMP is 
ruled out as the determination is based on the separation of two by 
TLC. 
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Study of the proposed experimental conditions 
To obtain the optimum conditions, the effect of different volumes 
ratio of NaXO, and K^S,0. are studied. It was found that a volume 
of 3.8 ml of 0.1 M sodium carbonate (Fig. 4.3) and 2.8 ml of 0.1 M 
potassium persulphate (Fig. 4.4) gives optimum results for 0.5 ml of 
trimethoprim. Under the optimum experimental conditions, the product 
is found to be stable after 30 min. of heating on a water bath at 
100°C (Fig. 4.5). Beer's law is obeyed over the concentration range 
of 10-60 fig/ml of trimethoprim at >.^ ^^  355 nm (Fig. 4.6), with apparent 
molar absorptivity of 2.7 x 10^1 moM cm ^ 
The reproducibility of the procedure is studied by running 10 
replicate samples, each containing 50 ^g/ml trimethoprim in the final 
solution. At this concentration level the standard deviation and the 
relative standard deviation are 0.32 ^g/ml and j : 0.53%, respectively. 
The presence of trimethoprim (TMP) in combination with 
sulphamethoxazole (SMX) required a prior separation of SMX which 
causes interference in its determination. The separation of TMP from 
SMX is carried out by thin layer chromatography using silica gel plates. 
Since the determination of TMP is based on its prior separation from 
SMX, the TLC technique is adopted which shows a wide difference 
in R^  values, enabling the possible quantitative determination of TMP. 
The R^  values are shown in Table 4.3. 
A study of possible interference caused by foreign substances 
in tablets and oral suspensions has been performed. The results are 
summarized in Table 4.1 . 
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In order to check the validity of the method, the results are 
compared with standard reference method. Standard deviation has 
been calculated by taking a sample of five determinations of TMP. 
The results are presented in Table 4.2. 
The proposed method is sensitive, valid at lov^er concentration 
range. The stability of the colour is high and is not affected by 
moisture as compared with the chloranil method. Moreover, the 
proposed method can be recommended for the routine analysis of 
trimethoprim in pharmaceutical preparations and drug control 
laboratory. 
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Table4.1. Maximum tolerance of foreign substances in the 
determination of trimethoprim (50 yiglm\) 
Foreign susbtances 
Sucrose 
Fructose 
Lactose 
Starch 
Glucose 
Maximum tolerance 
(mg) 
86.0 
45.0 
90.0 
40.0 
27.0 
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Table 4.3. R, values of trimethoprim and sulphamethoxazole by TLC 
using silica gel plates. 
Generic Name 
Tablets 
Septran 
(Wellcome) 
Ciplin 
(Cipla) 
Bactrim 
(Roche) 
Oriprim 
(Cadila H.C.) 
Oral suspensions 
Bactrim 
(Roche) 
Septran 
(Wellcome) 
R, values 
TMP 
0.16 
0.18 
0.28 
0.15 
0.17 
0.43 
SMX 
0.75 
0.83 
0.98 
0.75 
0.76 
0.94 
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/•20 
Fig. 4.1 Absorption spectrum of trimethoprim-persulphate in alkaline medium 
against a reagent blank at a temperature 100°C. 
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0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 A.5 
Amount of NQ2C03(ml) 
Fig. 4.3 Effectofsodiumcarbonateonthereactionprocluct,at100°C;X =355nm. 
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0.5 1.0 1.5 2.0 2.5 3.0 3.5 
Amount of Persulphate (ml ) 
Fig. 4.4 Effect of persulphate on the reaction product, at 100°C; X =355 nm. 
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10 15 20 25 30 35 /iO 
Time (min.) 
Fig. 4.5 Effect of time on the stability of trimethoprim at 100°C, X =355 nm. 
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Fig. 4.6 Calibration graph of trimethoprim, at a temperature 100°C; A,,^=355 nm. 
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Kinetic Spectrophotometric Determination 
of Menadione (2-Methyl-1,4 Naphthoquinone) 
in Pure form and Pharmaceutical Preparations 
Xt 
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Introduction 
Menadione (VK3), 2-methyl-1,4 naphthoquinone, is a synthetic 
vitamin K analog which has been used chiefly as an antihemorrhagic 
agent (1). Much interest has been generated in its potential as a 
clinically useful antitumor agent. Quinones are not aromatic compounds 
but are conjugated cyclic diketones, and play a vital role in the 
oxidation-reduction processes of living organisms. Quinones occur widely 
as natural pigments found mainly in plants, fungi, lichens, marine 
organisms and insects. Moreover, quinone exhibit a variety of redox 
reactions which are coupled to protonation reaction. The thermodynamic 
depends on the substituents of the quinone ring as well as on the 
environment (i.e., solvent) which surrounds the molecule. Through these 
reactions a great variety of species can be produced, however, some 
of which are only stable at extreme pH or at very negative potentials. 
This unique behaviour is probably the main reason why the quinones 
have been studied for more than 40 years with various techniques. 
Thus, trace analytical techniques for this compound are necessary 
for the study of their biological action as well as in pharmacological 
and toxicological studies. Menadione is determined spectrophotometrically 
using P-N-methylbenzoquinone monoimine (2). The method is applicable 
to pharmaceutical preparations and bulk samples. 
A spectrophotometric method for the determination of menadione 
is described (3). This method is based on the reaction of menadione 
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with isonicotinic hydrazide in the presence of ammonia. The resulting 
yellow-green colour is utilized for the determination of menadione. The 
concentration range is valid from 200-600 i^g/ml. Thin layer chromato-
graphic method for the detection of menadione is described (4). The 
TLC method is based on the detection of menadione on the plates 
using different aromatic amine such as (aniline, benzidine, o-toluidine 
and a-, or p-naphthylamine). The detection limit is 1 ng and the 
minimum amount for the semiquantitative is about 10 ^g. In another 
reaction, 2,4-dinitrophenylhydrazine (DNPH), in the presence of 
ammonia, is used as a successful reagent for the official assay of 
menadione injection (5). The blue-colored reaction product of DNPH 
with menadione is identified on the bases of visible light spectra and 
mass spectra. Menadione is determined spectrophotometrically using 
rhodanine, fluorene and semicarbazide hydrochloride (6). The method 
is selective and sensitive for quinone. Menadione has also been 
determined spectrophotometrically using acetylacetone, diethylmalonate 
and ethylcyanoacetate in the presence of ammonia (7). The 
determinations are based on a condensation reaction of menadione 
with the above mentioned reagents. The reaction is suitable for the 
determination of VK3 in the concentration range > 5 f.ig/ml with an 
accuracy of +0.2%. Differential pulse polarographic assay method is 
adopted for plasma vitamin K3 (menadione) (8). The lower sensitivity 
limit of the technique after addition of standard vitamin K3 to plasma 
is 0.3 pM; the calibration curve is Wnear from 0.6 -10 ^M. The official 
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B.P. method describes the titrimetric method for the assay of menadione 
(9), using ammonium cerium ( iv) nitrate as a titrant. The concentration 
of menadione is calculated, where each ml of 0.1M ammonium cerium 
(iv) nitrate is equivalent to 8.61 mg of menadione. The US official method 
described a spectrophotometric determination for menadione in injection 
(10) which Is based on using 2,4-dinitrophenylhydrazine as a reagent 
in acidic medium. The absorbance is measured at X^^^ 635 nm. A high 
performance liquid chromatographic method is described for the 
determination of menadione sodium^ bisulphite (vitamin K3) in animal feed 
and premixes(11). The method permits the determination of menadione 
at concentrations as low as 0.02 ng/g. A spectrophotometric method 
is also reported for the assay of menadione (12). The spectrophotometric 
method utilized the complex formed by the reaction of titanium (IV) with 
menadione. The method yields highly linear calibration in the region 
of 10-^M. To more spectrophotometric methods for the determination of 
menadione in pharmaceutical preparations are described (13). The 
methods are based on the reactions of menadione (VK3) or menadione 
sodium bisulphite with thiosemicarbazide and ethyl acetoacetate forming 
stable coloured species which are measured at 520 nm and 550 nm, 
respectively. Dimethylamine is used as a chromophoric reagent for the 
determination of menadione in drug dosage forms (14), resulting in 
the formation of a violet-red complex with X at 510 nm. TLC method 
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followed by spectrophotometric method is used for the micro-estimation 
of menadione in pharmaceutical preparations (15). The menadione 
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present in the tablets is separated by TLC, eluted and is determined 
ateeOnm. Aspectrophotometric method is described for the analysis 
of VK3 and its sodium bisulphite adduct in the presence of one another 
(16), The method is based on the increase of solubility of menadione 
at pH 4-7 in phosphate buffer and assaying at 234 nm and 253 nm. 
Simple, rapid and selective spectrophotometric method is described 
for the analysis of menadione (17). The determination is based on the 
reaction of menadione with piperidine and malononitrile resulting in the 
production of red and blue colours, respectively, with X^^^ at 510 nm 
and 580 nm. In addition to the above mentioned methods, several 
methods for the determination of menadione are also described in the 
literature (18-27). 
In this chapter, we describe a kinetic spectrophotometric 
determination of menadione and study of its interaction with dodecyl-
amine to develop a colour having a k^^^ at 470 nm. The kinetic studies 
show first order reaction for both menadione and dodecylamine. The 
recommended method can determine menadione in the range 10-80 ng/ 
ml. 
EXPERIMENTAL 
Reagents and solutions 
All the reagents used were of analytical grade and the solutions 
are prepared in distilled ethanol. 
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Pure menadione (Himedia Lab., India) solution (5.81 x10^mol/l) 
or 1 mg/ml was prepared in distilled ethanol. The standard solution is 
stable if kept in an amber-coloured bottle in the dark to prevent 
decomposition. The purity of the standard solution was checked by 
official (BP) method (9) and found to meet those requirements. 
Dodecylamine (Fluka), 2.7 mol/l stock solution was used without 
further purification. 
Apparatus 
A Bausch and Lomb spectronic - 20D* spectrophotometer (split-
Beam, Milton Roy), with 1 cm cell, and a controlled-temperature water 
bath were used. 
Procedure 
In 10 ml volumetric flasks, the final concentration of the standard 
pure solution of menadione ranging from 5.81 x 10"-4.65 x 10-^  
mol/l are placed, and 6 ml of 2.7 mol/l dodecylamine is added. The flasks 
are immersed in a water-bath maintained at a temperature 33°C. The 
flasks are taken out consecutively from the water bath at a time-interval 
of45 sec, cooled at room temperature and then diluted upto the 
mark with distilled ethanol. The contents are then transferred to the 
spectrophotometric cell and the absorbance-time curve at 470 nm 
Is recorded. The calibration graph is prepared by a plot of log R 
(Initial rate of reaction ) vs. log C (menadione concentration) (Table 5.1). 
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Determination of menadione 
Analysis of injection 
A quantity of 10 mg of menadione injection was transferred into 
10 ml standard flask and diluted upto the mark with distilled ethanol 
to produce a final concentration of 5.81 x10-^mol/l. 
Analysis of tablets 
In routine analysis, two tablets were crushed and grinded to a 
fine powder, and accurately weighed which was equivalent to 10 mg. 
The powder was dissolved in ethanol and diluted upto the mark in a 
10 ml standard flask. The residue was filtered through a whatman filter 
paper No. 1 with the final concentration of 5.81 x 10-^  mol/l. The 
recommended procedure was followed. 
RESULTS AND DISCUSSION 
The interaction of dodecylamine with menadione gives rise to an 
orange colour product with X^^^ at 470 nm (Fig. 5.1). The kinetics of the 
formation of the orange colour is studied at 470 nm. The increase of 
absorbance is measured as a function of time. The reaction of 
menadione with various amines has been checked and found not to 
give any interference. The results are summarized in Table 5.2. 
To study the rate of reaction with respect to menadione 
(keeping dodecylamine concentration constant) at a temperature 33°C, 
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absorbance versus time observations are recorded (Table 5.3). A plot 
of log Ax)/Aoc-At vs. time (t) gives a straight line (Fig. 5.2) whose 
slope gives the direct measurement of rate constant (K) of the 
reaction at 33°C (Table 5.3). Similarly the rate of reaction with respect 
to dodecylamine (keeping menadione concentration constant) at a 
temperature 33°C, absorbance versus time are reported in Table 5.4 and 
a plot of log Ax7Ax-At vs. time (t) also gives a straight line (Fig. 5.3). 
Its slope gives the direct measurement of rate constant (K) of the reaction 
at 33°C (Table 5.4). The kinetic studies with respect to menadione and 
dodecylamine gave first order plots (Figs. 5.4 (a,b) and 5.5(a,b)). 
Effect of temperature 
The effect of temperature on the reaction rate is studied in the 
range (306-327 K). Processing of the temperature effect on the 
reaction rate to evaluate AE* (energy of activation), according to 
Arrhenius equation, K = Ae "^ ^ ' ^ \ is presented in a plot of In k 
(reaction rate) vs. 1/T(Fig. 5.6). The estimation of the free energy of 
activation from the relation K, = (KT/h)e '^^ '^'^ (where K and h are 
Boltzmanand Plank's constants, respectively), resulted in the evaluation 
of AS* and AH* from the Gibb's Helmholtz equation (AG* = AH*-TAS*). 
Thus, a plot of AG*/T vs. 1/T(K) (Fig. 5.7) is obtained. The values of 
AH* and AS* are obtained from the gradient and intercept of Fig. 5.7. 
The results for the activation parameters are summarized in Table 5.5. 
Menadione in pharmaceutical preparation has been determined 
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using calibration curves (Figs. 5.4(a,b)) and the results are found 
satisfactory (Table 5.6). The validity of the recommended procedure 
has been checked by comparing the results obtained by reference 
method (13) (Table 5.7). Moreover, the results showing maximum tolerance 
of the foreign substances with minimum amount of menadione have been 
summarized in Table 5.8. The work is still in progress to establish the 
mechanism of the reaction. 
In conclusion, the present method is simple, sensitive and superior 
to other methods (2-6) in terms of less time consuming. Therefore, the 
method proposed in suitable for the determination of menadione in pure 
form and pharmaceutical preparations. 
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Fig. 5.1 Absorption spectrum of menadione - dodecylamine reaction product at 
33°C;X 470nm. 
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Fig. 5.2 Plot of log Aoo/Aoo-At vs. time: between menadione and dodecylamine 
at 33°C. Menadione volume are: (a) 0.1 ml; (b) 0.2 ml; (c) 0.6 ml; (d) 0.8 
ml. Keeping dodecylamine concentration constant (1.62mol/l). 
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Fig. 5.3 Plot of log Aoo/Aoo-At vs. time : between dodecylamine and menadione 
at 33°C. Dodecylamine volumes are (a) 3 ml; (b) 4 ml; (c) 6 ml; (d) 7 ml. 
Keeping menadione concentration constant (4.65 x 10-^  mol/l). 
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